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A Best Practice Guideline about Dialysis ﬂuid purity was developed under the leadership of
the Spanish Society of Nephrology in 2004. The second edition revised Guideline considered
new evidences and International Standard. The guideline has established recommendations
for  standards for preparing dialysate: water, concentrates and haemodialysis proportioning
systems. This guideline is based on the ISO 13959, European Pharmacopoeia, the Real Farma-
copea Espan˜ola, the AAMI Standards and Recommended Practices, European Best Practiceialysate
ater treatment for dialysis ﬂuid
aemodialysis
oncentrate
ndotoxins
Guidelines for Haemodialysis, literature reviews, according to their level of evidence, and
the  opinion of the expert Spanish group.
Two levels of quality of water were deﬁned: puriﬁed water and high puriﬁed water
(ultra pure) and for dialysate: ultra pure dialysate. Regular use of ultra pure dialysate is
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recommended for all type of haemodialysis to prevent and delay the occurrence of compli-
cations: inﬂammation, malnutrition, anaemia and amiloidosis.
Water,  concentrates and dialysate quality requirements are deﬁned as maximum allow-
able contaminant levels: chemicals (4.1.2), conductivity, microbial and endotoxins (4.1.1):
Microbial (CFU/ml) Endotoxins LAL test (EU/ml)
Puriﬁed water ≤100 CFU/ ml ≤0.25
High puriﬁed water ≤10 CFU/100 ml ≤0.03
Ultra pure dialysate ≤10 CFU/100 ml ≤0.03
Monitoring frequency, maintenance and corrective actions were speciﬁed. Methods of
sampling and analysis were described in Appendix. For microbiological monitoring, R2A
medium is recommended, incubated during 7–14 days at a temperature of 17–23 ◦C.
The  dialysate quality assurance process involves all dialysis staff members and requires
strict protocols. The physician in charge of haemodialysis has the ultimate responsibility
for  dialysate quality.
All suggestions and questions about this Guideline are welcome to www.senefro.org.
©  2016 Published by Elsevier Espan˜a, S.L.U. on behalf of Sociedad Espan˜ola de Nefrologı´a.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
Guía  de  gestión  de  calidad  del  líquido  de  diálisis  (LD)  (segunda  edición,
2015)
Palabras clave:
Líquido de diálisis
Tratamiento de agua para
hemodiálisis
Hemodiálisis
Concentrado
Endotoxinas
r  e  s  u  m  e  n
La Sociedad Espan˜ola de Nefrología elaboró en 2004 una Guía de Gestión de Calidad del
Líquido de Diálisis. La segunda edición revisada de la guía ha tenido en cuenta nuevas evi-
dencias y la normativa internacional. En la guía se hacen algunas recomendaciones sobre
normas para preparar el líquido de diálisis: agua, concentrados y sistemas de dosiﬁcación
de  la hemodiálisis. Esta guía se basa en la norma ISO 13959, la Farmacopea Europea, la Real
Farmacopea Espan˜ola, las normas y prácticas recomendadas de la AAMI, la Guía Europea de
Buena Práctica en Hemodiálisis, revisiones de la bibliografía, según su nivel de evidencia, y
la  opinión del grupo espan˜ol de expertos.
Se deﬁnieron 2 niveles de calidad del agua: agua puriﬁcada y agua puriﬁcada de alta cal-
idad (ultra pura), y para el líquido de diálisis: líquido de diálisis ultra puro. El uso habitual
de  líquido de diálisis ultra puro se recomienda en todo tipo de hemodiálisis para prevenir y
retrasar la aparición de complicaciones: inﬂamación, desnutrición, anemia y amiloidosis.
Los  requisitos de la calidad del agua, de los concentrados y del líquido de diálisis se deﬁnen
como los niveles máximos admisibles de contaminantes: sustancias químicas (4.1.2), con-
ductividad, microbiana y endotoxinas (4.1.1):
Microbiana (UFC/ml) Endotoxinas prueba LAL (UE/ml)
Agua puriﬁcada ≤100 UFC/ ml ≤0,25
Agua ultra pura ≤10 UFC/100 ml ≤0,03
Líquido de diálisis ultra puro ≤10 UFC/100 ml ≤0,03
Se especiﬁcaron la frecuencia de control, el mantenimiento y las medidas correctivas. Los
métodos de muestreo y análisis se describieron en los anexos. Para el control microbiológico
es  recomendable el medio de cultivo R2A, incubado durante 7–14 días a una temperatura de
17–23 ◦C.
El proceso de garantía de la calidad del líquido de diálisis implica a todos los miembros
del  personal de diálisis y exige protocolos estrictos. El médico a cargo de la hemodiálisis
tiene  la responsabilidad ﬁnal de la calidad del líquido de diálisis.
Pueden dirigir sus sugerencias y preguntas acerca de esta guía a www.senefro.org.
©  2016 Publicado por Elsevier Espan˜a, S.L.U. en nombre de Sociedad Espan˜ola de
Nefrologı´a.  Este es un artı´culo Open Access bajo la licencia CC BY-NC-ND (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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.  Introduction
ntroduction  to  the  2004  edition
ialysate or dialysis ﬂuid (DF) is one of the basic elements of
aemodialysis (HD). It is a liquid medium which comes into
ontact with the blood through the semipermeable membrane
n the dialyser during haemodialysis. It allows the exchange of
ubstances, essentially solutes, with the blood, in both direc-
ions.
It is an electrolyte solution prepared extemporaneously by
he haemodialysis machine (HDM) from puriﬁed water and
olutes provided in the form of electrolyte concentrates or
ndissolved salts. Prepared in this way, dialysate is virtually
sotonic and its electrolyte composition is similar to plasma.
here are differences in the concentrations depending on the
radients necessary to achieve the appropriate balance of each
ubstance according to the needs of the patient.
Dialysate quality and purity are two of the most critical
equirements of haemodialysis. The presence of contami-
ants in the dialysate exposes the patient to the risk of toxic
ubstances accumulating and consequent acute and chronic
omplications. Some contaminants can interact with cells or
roteins, triggering bio-incompatibility on top of that caused
y other components of the extracorporeal blood circuit in
aemodialysis.
Dialysate quality and purity are the result of a complex
eries of processes in which any error has a huge impact on
he ﬁnal product. It is therefore necessary to monitor all the
lements and steps involved in the entire production chain.
he preparation, distribution and storage conditions must be
esigned to minimise the risk of chemical and microbiological
ontamination.
For ease of understanding, this guideline consists of six key
ubject areas:
. Water treatment systems (Section 4 and Appendix A.2.1).
. Electrolyte concentrates and powdered salts (Section 5 and
Appendix A.2.2).
. Haemodialysis machine (Section 6.3 and Appendix A.2.3).
. Quality control (Section 7 and Appendices 3 and 5).
. Methods for correction and prevention (Section 8 and
Appendix 4).
. Dialysate quality management (Section 9).
The guide includes: a glossary of terminology with ref-
rences to the corresponding sections (Section 2); a quick
uide with the standards (in bold) and key recommenda-
ions, divided into six sections (Sections 4–9); Section 10 with
he rationale and evidence supporting the recommendations
Section 10); and Appendices 1–6 describing equipment com-
onents and methodology.
ntroduction  to  the  2015  editionhe purpose of this ﬁrst revision of the Sociedad Espan˜ola
e Nefrología (SEN) [Spanish Society of Nephrology] Guideline
or Dialysate Quality (GDQ), published in Nephrology 2004;24 6(3):e1–e52 e3
Suppl. 2:1–42, is to update it and bring it into line with
haemodialysis today.
It is 11 years since the 1st edition of the GDQ and
haemodialysis has evolved:
1. Most haemodialysis (HD) in our area is high-ﬂux (80–90%)
and the proportion of patients on on-line haemodiaﬁltra-
tion (OL-HDF) has increased signiﬁcantly (20–30%). Today’s
HD requires ultrapure dialysate.
2. HD water treatment technology has also evolved. The effec-
tive treatment systems available these days for the water
used in HD maintain fairly uniform standards.
3. Although many  of the HD water treatment systems in Spain
have been renewed and improved, contamination above
the speciﬁed limits continues to occur; mainly microbiolog-
ical or involving aluminium and chloramines. Prevention of
contamination must therefore be a goal.
4. Maintaining the standard of highly puriﬁed water contin-
ues to create technical problems in many  HD units. Certain
requirements for highly puriﬁed water need to be reﬁned
or modiﬁed without affecting the requisite quality.
5. Aspects relating to dialysate quality not covered in the ﬁrst
edition need to be included, such as feed water supply
characteristics, testing methods for certain contaminants,
portable and home water treatment systems and monitor-
ing of central concentrate delivery systems.
The GDQ has set the standard to be followed in terms of HD
water and dialysate quality in Spain and other countries. Many
of the Spanish Autonomous Regions have used it for their
technical speciﬁcations and agreements for HD. The Ministry
of Health, Social Policy and Equality included it as a reference
in its Standards and Recommendations for extrarenal blood
puriﬁcation (haemodialysis) units in 2011. The GDQ helped
create a culture of awareness about the importance clinically
of ultrapure dialysate, which was subsequently endorsed by a
large volume of scientiﬁc evidence. It has been pioneering in
a number of ways, one being that the microbiological testing
methodology proposed in the 2004 GDQ is similar to that of
the 2014 ISO 13959.
We  have attempted to make the terms of this guide-
line more  readily understandable and interpretable. We have
therefore standardised the terminology used, as described in
Section 3.3.
The GDQ was commissioned to a group of experts by the
SEN. This revision has been commissioned by the present SEN
Board of Directors, chaired by Dr Maria Dolores del Pino, to a
new group of experts.
2.  Glossary  of  terms  and  deﬁnitions
AAMI: Association for the Advancement of Medical Instru-
mentation: Recommends standards for medical proce-
dures in the United States of America. www.aami.org. See
Appendix 6.Action level: Degree of contamination at which implemen-
tation of corrective measures is recommended to avoid
reaching unacceptable contamination limits. See Section
4.1.1.
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Activated charcoal ﬁlter: Filter used to remove chlorine, chlo-
ramines and organic substances from water by means of
adsorption onto the microporous structure of the activated
charcoal. See Appendix A.2.1.
Actual volume of a bed: The volume of a bed in a container.
The space between the particles is considered as volume
occupied by the bed itself. See Appendix 2.
Ao: Ao is a way of calculating the “dose of thermal energy
necessary” to disinfect, based on different combinations of
time and temperature. One Ao equals one second at 80 ◦C.
(1 Ao = 1 second at 80 ◦C). Ao =
∑
10 (T − 80)/z·t, where T
is temperature in ◦C; z equals 10 ◦C; and t is the time in
seconds. See Section 8.
Backwash: Process for a bed ﬁlter consisting of introducing
water from the bottom to ﬂow upwards to expand the bed
and allow removal of retained particles. To be effective, the
water velocity should be slightly greater than the ﬂuidis-
ation velocity to achieve expansion of the bed by at least
10%. See Appendix 2.
Bed expansion: Increase in the bulk volume of a bed when
subjected to a backwash cycle. See Appendix 2.
Bed ﬁlter: Filter consisting of a container ﬁlled with a rigid
material of uniformly sized granules that retains particles
in the free spaces. Backwashes are necessary to remove
retained particles. See Appendix 2.
Bioﬁlm: Colonies of bacteria settled on the surfaces of
hydraulic circuits, protected by an ecosystem of precipi-
tated minerals and an extracellular mucopolysaccharide
matrix, which reproduce and generate in stagnant condi-
tions. The presence of bioﬁlm is associated with persistent
bacterial contamination. It is an active source of endo-
toxins and other biologically active bacterial derivatives.
It is resistant to the majority of disinfectants. See
Appendix 3.
Buffer tank: Tank installed at the beginning of a water treat-
ment plant to provide a constant ﬂow rate. Its function
is not to store water, but to stabilise the process and not
depend on the feed water supply pressure. See Appendix 2.
Bulk volume of a bed: The volume of a bed when expanded
with a backwash cycle. See Appendix 2.
Cartridge ﬁlter: Consists of a cylinder of porous material
which retains particles smaller than the pore size when
water is passed through it. See Appendix 2.
Chemosynthetic bacteria: Bacteria capable of synthesising
their nutrients and obtaining energy from inorganic com-
pounds. See Appendix 2.
Chloramines: Products formed by the combination of free
chlorine and ammonium. The ammonium can come from
decomposition of vegetable matter and other organic
pollutants, or be added by those responsible for the
water’s potability in order to disinfect it. Chloramines are
extremely oxidative and toxic for patients on haemodialy-
sis. See Appendix 5.
Colony-forming units (CFU): Unit of measurement of viable
bacteria. Refers to the number of bacterial colonies which
have developed in a solid culture medium. Expressed as
CFU per millilitre of ﬂuid. See Appendix 3.Combined chlorine: Chlorine chemically bound to other com-
pounds, like chloramines. Total chlorine equals free plus
combined chlorine. See Appendix 5.;3  6(3):e1–e52
Concentrates for dialysis: Concentrates or salts to be mixed
with the puriﬁed or highly puriﬁed water in the haemodial-
ysis machine to form the dialysate. These concentrates
or salts are manufactured, packaged and labelled to CE
marking standards and must comply with ISO 13958. See
Section 5.
Conductivity: Measure of a material ability to conduct an
electric current and is the inverse of resistivity. The con-
centration of electrolytes in water is directly related to the
electrical conductivity of the solution. It is measured in
S cm−1. See Section 10.8.
Continuous electric deionization (CDI) or electro-
deionization (EDI) system: Device for reducing the con-
centration of free ions in the water, cations and anions,
applying an electric ﬁeld. See Appendix A.2.1.
Deioniser (DI): Device for reducing the free ions in the water,
with dual-bed or mixed-bed cationic and anionic resins.
See Appendix 2.
Dialysate: Aqueous ﬂuid containing electrolytes, buffers and
usually glucose, which is formed by combining water and
dialysis concentrates and salts in the dialysis machine. The
terms dialysis ﬂuid, dialysis solution or dialysis bath are
synonymous. See Section 6.
Dialyser: Haemodialysis machine in which the dialysis takes
place by way of diffusive and convective transport and
adsorption. Inside, the blood and dialysate come into con-
tact through a semipermeable membrane. Also called a
ﬁlter.
Disinfection: Process for destruction of microorganisms,
which reduces their numbers but does not eliminate them.
Sterilisation reduces the numbers to a safe level, since total
elimination is virtually impossible. Can be done by chemi-
cal or thermal means. See Section 8.
Electro-medical equipment: Active non-implantable medical
device (ANIMD) and as such, subject to European and
national regulations (i.e. RD1591/2009, Medical Devices
Directive, 93/42/CEE, ISO13485, IEC 60601.1:2015). See
Appendix 6.
Empty Bed Contact Time (EBCT): Contact time between the
water and the activated charcoal bed. Calculated by the
equation EBCT = (7.48 * V)/Q, where V is the bulk volume of
the bed and Q the water ﬂow expressed in gallons/min. See
Appendix A.2.1.
Endotoxin units per ml  (EU/ml): Units of endotoxin (ET)
quantiﬁed by a test based on Limulus amoebocyte lysate
(LAL) activation. ET activity varies according to its com-
position, so its activity is compared to the E. coli standard
(O 113: H10). The relationship between the activity and
the mass varies with the batch of LAL and batch of ET
standard. Generally, 0.012 endotoxin units are equivalent
to approximately one picogram. The ratio is generally 10
EU per ng. Chromogenic determination is the most sensi-
tive, although other methods (colorimetric, ﬂuorimetric,
GEL-CLOT) are routinely used in these determinations. See
Appendix A.3.2.
Endotoxin: Biologically active pyrogenic substance,
lipopolysaccharide, released from the outer cell wall
of gram-negative bacteria. They are measured in Endo-
toxin Units, EU/ml, or in International Units, IU/ml, which
are now equivalent. See Appendix 3.
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xotoxin: Protein with pyrogenic activity secreted by microor-
ganisms. See Appendix 3.
eed or raw water: Feed water means the water to be treated,
whether it comes from the municipal water supply, is taken
from a well or is delivered by tankers. In general it is potable
water, which in Spain is subject to the relevant regulations.
See Appendices 1 and 5.
luidisation velocity: The velocity of backwashing of a bed ﬁl-
ter to which the ﬁlter is subjected to an upward force equal
to its weight. Its bulk volume does not vary; expansion is
zero. See Appendix 2.
orward rinse: Process for a ﬁlter bed consisting of intro-
ducing water at the top and removing the water used
in the backwash, which has not been ﬁltered. See
Appendix 2.
ree chlorine: Dissolved molecular chlorine. See Appendix 5.
aemodiaﬁltration: Form of haemodialysis in which, along-
side diffusive transport, convective transport plays an
important role in solute removal.
aemodialysis machine: Machine or system that carries out
the haemodialysis process. The dialysis process takes place
in a dialyser where the blood circuit and the hydraulic cir-
cuit combine to produce the dialysate. These two circuits
are controlled by the machine with maximum efﬁcacy and
safety for the patient.
aemodialysis: Form of renal replacement therapy that
involves the removal of solutes from the blood and
exchange of solutes between the blood and the dialysate.
The solutes are preferentially removed by diffusion.
eterotrophic bacteria: Bacteria, which metabolically,
require organic compounds to develop. This is a broad
and diverse group that includes symbiotic, saprophytic
and pathogenic species. The term heterotrophic is com-
monly used as a generic name for water bacteria with few
nutritional requirements. See Appendix 3.
SO: International Standardization Organization. See Appendix 6.
imulus Amoebocyte Lysate (LAL) test: Speciﬁc detection
assay for endotoxins, based on horseshoe crab, Limulus
polyphemus, amoebocyte lysate. See Appendix 3.
ipopolysaccharides (LPS): Endotoxins composed of lipids
and sugars (polysaccharides). See Appendix 3.
icroﬁlter: Filter able to remove particles larger than 1 m
in diameter (0.1–0.3 m according to the ISO). See
Appendix 2.
anoﬁltration: Retains organic compounds with molecular
weights between 300 and 1000 D, retains some salts and
works at lower pressure than RO. See Appendix 2.
ominal ﬂow rate: The ﬂow rate produced by reverse osmosis
equipment under ideal conditions. See Appendix 2.
ermeate or “ﬁltrate”: Fluid that has passed through a reverse
osmosis membrane. See Appendix A.2.1.
leated cartridge ﬁlter: Cartridge ﬁlter consisting of a rigid
perforated core in which the porous material is very thin
and has a large surface area, “a kind of paper” folded in
zigzag formation, sealed at both ends and attached to the
core. The ﬁltering capacity is determined by the porosity of
the ﬁlter material. Can retain particles and bacteria up to
0.2 m.  See Appendix 2.
re-ﬁlter or “sediment or sand ﬁlter”: Bed ﬁlter that removes
large particles, from 500 to 20 m,  positioned at the point of 6(3):e1–e52 e5
entry of the water into the treatment. Allows backwashing.
See Appendix A.2.1.
Pre-treated water: Water that has undergone all the pro-
cesses before reaching the osmosis or treatment equip-
ment. See Appendix 2.
Puriﬁed water: Water for the preparation of drugs or dialy-
sis ﬂuids which do not necessarily need to be sterile or
pyrogen-free. See Section 4.1 of this guideline.
Pyrogen: Substance that causes fever or inﬂammation. Exter-
nal pyrogens (endotoxins/exotoxins, bacterial DNA)  induce
cytokines such as IL-6, IL-1 or TNF, which are mediators in
the induction of fever and inﬂammation. Substances capa-
ble of activating mononuclear blood cells. See Appendix
3.
Pyrogen-free sterile water: Water free of live organisms and
spores. Sterility is deﬁned as the presence of fewer
than 1 × 10−6 CFU/ml viable bacteria or <0.03 EU/ml. See
Appendix 3.
R2A: Culture medium for bacteria which, due to its high sen-
sitivity, is particularly indicated for water contaminants.
For composition see Appendix A.3.1.
Reject or “concentrate” water: Water that has not passed
through the osmosis membranes and contains practically
all the salts and contaminants. See Appendix 2.
Resin: Cations, anions or mixture attached to granules in ion
exchange beds, such as in water softeners and deionisers.
See Appendix 2.
Resistivity: Resistance of a material to the ﬂow of electric-
ity through it. It is the inverse of conductivity. The fewer
the electrolytes, the greater the resistivity. Resistivity of
1 M/cm is the same as conductivity of 1 S/cm. See
Section 10.8.
Reverse osmosis (RO): Water puriﬁcation process which
works by sieving through a membrane and rejection of
ion concentrate. Removes ions and organic contaminants
with molecular weight >100 D. See Appendix A.2.1.
SDI: Silt Density Index. Parameter that measures the density of
sediments or the fouling tendency of water. Measurement
of this index is regulated by ASTM International (formerly
American Society for Testing and Materials). See Section
10.5.
Substitution ﬂuid: Fluid or dialysate used in haemoﬁltration
and haemodiaﬁltration and infused into the blood circuit
to replace the ultraﬁltrate. It is mandatory for this to be
ultrapure dialysate and undergo a second ultraﬁltration for
endotoxins. It can also be used for priming and ﬂushing the
blood circuit, as bolus, as infusion during the session or in
blood return. Also called infusion ﬂuid. See Section 6.
TDS: Total dissolved solids. Sum of all dissolved ions. Related
to the electrical conductivity and used to test the effective-
ness of reverse osmosis. See Section 10.8.
TGEA: Culture medium for bacteria, recommended by the ISO
and the European Guidelines, along with R2A. Composi-
tion: Tryptone glucose yeast extract agar. See Appendix
A.3.1.
TSA: Culture medium for bacteria. For composition see
Appendix A.3.1.
Ultraﬁlter: Membrane ﬁlter (polysulfone, polyamide,
polyethersulfone, posidyne) used to remove microbial
components from dialysis water, post-treatment in the
2 0 1 6e6  n e f r o l o g i a. 
dialysis water or, most commonly, in dialysis ﬂuids. Some
ultraﬁlters retain ET by adsorption. Also used as a synonym
of dialyser. See Appendix 2.
Ultraﬁltration, as dialysis method: Convective transport of
solutes across a membrane driven by a hydrostatic pressure
gradient (transmembrane pressure).
Ultraﬁltration, as treatment of dialysate: Process similar to
RO. Rejects contaminants between 1000 D and 0.1 m.
Ultraﬁltration requires low pressures to operate. Essentially
retains organic substances, bacteria and pyrogens. The
effectiveness of ultraﬁltration membranes is determined
as the lowest molecular weight that rejects more  than 90%
(Molecular Weight Cut-off [MWCO]). See Appendix 2.
Ultrapure dialysate: Dialysate, preferably produced with
highly puriﬁed water, with fewer than 0.1 CFU/ml and
fewer than 0.03 EU/ml which has passed through an
ultraﬁlter immediately pre-dialyser. See Section 6.
Ultrapure water: Ultrapure or highly puriﬁed water is deﬁned
as water meeting the recommendations on content in
chemical contaminants listed in Section 4.1.2. Maximum
conductivity is 5 S cm−1, measured at 25 ◦C, bacterial con-
tamination is less than 0.1 CFU/ml (10 CFU/100 ml)  and
endotoxin levels must be less than 0.03 EU/ml. See Section
4.2.
Ultraviolet: Bactericidal ultraviolet radiation used to kill
microorganisms. UVC, wavelength-energy-photon:
200–290 nm and 6.2–4.3 eV. 254 nm is recommended
and 16 milliwatt-s/cm2 followed by use of an endotoxin
ﬁlter. ISO 13958:2009. See Appendix 2.
USP: United States Pharmacopoeia. See Appendix 6.
Venting: Entry and exit of air that occur when the volume of a
liquid stored in a rigid container varies. It may have a 0.2 m
ﬁlter in order that the air entering meets speciﬁcations. See
Appendix 2.
Water softener: Device for reducing water hardness by
removing the calcium and magnesium by ion exchange
with cations ﬁxed on resins. See Appendix A.2.1.
Wound cartridge ﬁlter: A cartridge ﬁlter formed by a rigid per-
forated tube or core in which the porous material consists
of a cord made of cotton, polypropylene or other similar
material; depending on the type of yarn, the number of
threads per revolution and the winding pressure, varying
ﬁltering capacity is obtained. Can retain particles from 1 to
100 m.  See Appendix 2.
Abbreviations
AAMI: Association for the Advancement of Medical Instru-
mentation: www.aami.org
CDI: Continuous electric deionization or electro-
deionization system
CK: Cytokines or interleukins
CSA: Canadian Standards Association
DI: Deioniser
EBCT: Empty bed contact time; contact time with the acti-vated charcoal bed
EDI: Continuous electric deionization or electro-
deionization system
HD: Haemodialysis;3  6(3):e1–e52
HDF: Haemodiaﬁltration
OL-HDF: On-line haemodiaﬁltration
HF: Haemoﬁltration
ISO: International Organization for Standardization
LAL: Limulus Amoebocyte Lysate
DF: Dialysis ﬂuid (dialysate)
LPS: Lipopolysaccharides/Endotoxins
HDM: HD machine
RO: Reverse osmosis
ppm: parts per million
TMP: Transmembrane pressure
R2A: Reasoner’s 2A culture medium
SDI: Silt Density Index
PS: Pyrogenic substances
LAL test: Limulus Amoebocyte Lysate (LAL) test
EBCT: Empty Bed Contact Time (contact time with the acti-
vated charcoal bed)
TDS: Total dissolved solids
TGEA: Tryptone glucose yeast extract agar
TSA: Bacto Tryptic Soy Agar; Soybean-Casein Digest Agar
EU: Endotoxin Units
IU: International Units of endotoxins
CFU: colony-forming units
USP: United States Pharmacopoeia
3.  Objective,  scope  and  methodology
3.1.  Objective
The purpose of this guideline is to provide recommendations
on quality for water, concentrates and dialysate in order to
ensure that haemodialysis is effectively performed. The aim
of effective haemodialysis is to promote optimal treatment for
patients on haemodialysis. This guideline aims to provide uni-
ﬁed criteria on the necessary quality of water, concentrates
and dialysate, along with methods for achieving and main-
taining that level of quality.
3.2.  Scope
The scope includes all types of haemodialysis or haemodi-
aﬁltration or any extrarenal blood puriﬁcation technique that
uses dialysate. Geographically, the scope of application of this
guideline is the Spanish National Health Service, as it is specif-
ically adapted to the practice of haemodialysis in Spain today.
It is intended to be seen as a goal for maintaining or achieving
quality in Spanish haemodialysis units, and the hope is that
its recommendations will be taken on board by all healthcare
workers, dialysis technicians and companies engaged in the
ﬁeld of dialysis.
3.3.  Methodology
Creation of the expert group:  The Spanish Society of Nephrol-
ogy appointed a nephrologist with extensive experience in
haemodialysis, and coordinator of the ﬁrst edition of this
guideline (2004), as coordinator of this second edition; the
multidisciplinary working group was then set up, including
four nephrologists and other specialists, experts in various
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echnical and scientiﬁc aspects related with water treatment,
 microbiologist, four haemodialysis technicians, a product
anager and a renowned researcher in the area of biocompat-
bility in dialysis. The multidisciplinary approach is essential
o provide a comprehensive picture of the subject, not only
or the theoretical aspect of the literature review, but from the
erspective of experience in day-to-day practice.
Dynamics of meetings: The ﬁrst meeting was to decide on
he aspects to be studied and divide them among the differ-
nt experts. At subsequent meetings, each expert’s proposals
ere discussed in an effort to reach a consensus on conclu-
ions. A ﬁnal face-to-face consensus meeting was then held.
An information search was carried out, covering lit-
rature (Medline/PubMed, Cochrane) other guidelines (see
ppendix 6), reports by quality control agencies and technol-
gy assessments (ISO, European Pharmacopoeia, AAMI, etc.;
ee Appendix 6).
Analysis of the quality of the evidence: The grading system
sed was Grades of Recommendation Assessment, Devel-
pment, and Evaluation (GRADE) (Uhlig K et al. Grading
vidence and recommendations for clinical practice guide-
ines in nephrology. A position statement from kidney
isease: improving global outcomes (KDIGO). Kidney Inter
006;70:2058–2065). The quality (level) of evidence (A–D) and
he strength of the recommendation (1–3) were arrived at
y consensus at the proposal of the authors of each chap-
er. The quality of water, concentrates and dialysate can at
imes be a special case in terms of grading level of evi-
ence. This area has been addressed in the ISO-AAMI. In some
nstances in this guideline, we  have adhered to the latest edi-
ions of the ISO standards in order to meet one of the main
bjectives, which was to unify criteria with other recommen-
ations/international guidelines.
The terminology used in this guideline has been standard-
sed in relation to the level of evidence or the ISO standards as
ollows:
 “shall” means that compliance with a requirement or a test
is mandatory (required = strong recommendation)
 “should” means that compliance with a requirement or a
test is recommended, conditional on what is explained for
that instance (recommended = weak recommendation)
 “may”  is used to describe a permissible way to achieve
compliance with a requirement or test (permissible or not
graded)
.  Purity  and  quality  of  water  for
aemodialysis
s a basic rule, any treatment system for water for
aemodialysis must be designed to, at the very least, meet the
peciﬁcations for chemical and bacteriological levels recom-
ended in this guideline, including in terms of maintenance
f that system over time.
Water used for haemodialysis is divided into two distinct
ypes: standard or puriﬁed water (4.1); and ultrapure or highly
uriﬁed water (4.2). Each type has different criteria for micro-
iological quality and endotoxins. The current position of
hese guidelines is to recommend that highly puriﬁed water 6(3):e1–e52 e7
shall be used in haemodialysis units as the main component
of ultrapure dialysate.
4.1.  Puriﬁed  water  for  haemodialysis
4.1.1.  Microbiology
Maximum  allowable  levels  for  microbiological  purity.  In terms
of bacteriological requirements, puriﬁed water used for
diluting the dialysis concentrate shall contain fewer than
100 CFU/ml. ISO 13959. 3rd edition 2014.
Speciﬁcations.  These CFU ﬁgures correspond to the average
of the total number of viable aerobic bacteria able to form a
visible colony for each sample spread on R2A medium and
incubated for 7 days between 17 ◦C and 23 ◦C (ISO 13959, 3rd
edition 2014).
Although there is little literature base to support it, fungi
should not exceed 10% of the total colonies of aerobic organ-
isms (Evidence level C, 2).
For additional speciﬁcations and recommendations on this
section, consult Appendix A.3.1.
Action  levels  for  microbiological  purity.  We  recommend that
corrective measures, i.e. disinfection, be commenced when
bacterial counts reach 50% of the mandatory limit: presence
of more than 50 CFU/ml of viable aerobic bacteria ISO 13959.
3rd edition 2014. Disinfection should also be performed with
lower contamination levels if visible in more  than one sample
in order to prevent the formation of bacterial bioﬁlm.
Maximum  allowable  levels  of  endotoxins.  The endotoxin con-
tent in puriﬁed water for haemodialysis shall not exceed
0.25 EU/ml, measured by a sufﬁciently sensitive LAL test. ISO
13959. 3rd edition 2014.
Determination of the bacteriological quality of the water
and the dialysate shall include testing for microorganisms and
endotoxins.
4.1.2.  Maximum  allowable  levels  of  chemical
contaminants
Puriﬁed water for haemodialysis shall not contain contam-
inant concentrations greater than those listed below (ISO
13959:2014 [see Appendix 5]):
– Aluminium: Atomic absorption
spectrometry
0.01 mg/l (10 g/l)
– Antimony:  Atomic absorption
spectrometry
0.006 mg/l
– Arsenic: Atomic absorption
spectrometry
0.005 mg/l
– Barium: Atomic absorption
spectrometry
0.100 mg/l
– Beryllium:  Atomic absorption
spectrometry
0.0004 mg/l
– Cadmium:  Atomic absorption 0.001 mg/l
spectrometry
– Calcium: Atomic absorption
spectrometry
2 mg/l
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– Chromium: Atomic absorption
spectrometry
0.0140 mg/l
– Copper: Atomic absorption
spectrometry
0.100 mg/l
– Fluoride: Ion chromatography 0.200 mg/l
– Lead: Atomic absorption
spectrometry
0.005 mg/l
– Magnesium: Atomic absorption
spectrometry
4  mg/l
– Mercury: Atomic absorption
spectrometry
0.0002 mg/l
– Nitrate, as N Colorimetry 2.0000 mg/l
– Potassium: Flame photometry 8 mg/l
– Selenium: Atomic absorption
spectrometry
0.0900 mg/l
– Silver:  Atomic absorption
spectrometry
0.005 mg/l
– Sodium: Flame photometry 70 mg/l
– Sulfate: Turbidimetry 100 mg/l
– Thallium:  Atomic absorption
spectrometry
0.0020 mg/l
– Total chlorine: Colorimetry 0.100 mg/l
– Zinc: Atomic absorption
spectrometry
0.100 mg/l
All these elements shall be tested at least once a year.
Testing for aluminium shall be six-monthly.
For more details regarding the analysis technique, please
consult Table 3 of ISO 13959:2014.
Puriﬁed water shall have maximum conductivity of
5 S cm−1 at 25 ◦C (Appendix 5). In exceptional situations,
below 20 S cm−1 at 25 ◦C shall be allowed while the cause
of the increase in conductivity is being identiﬁed. (Level of
Evidence C, 2)
If, despite having a water treatment system with dou-
ble osmosis in series or osmosis plus an electro-deionization
system in series, conductivity of 5 S cm−1 is not reached, pro-
vided it is below 20 S cm−1 and all chemical contaminants
listed in Section 4.1.2 are within speciﬁed limits, the existing
level of conductivity shall be set as reference. In such cases,
the cause of the increase in conductivity (e.g. carbon dioxide,
pH, Na, etc.) shall be identiﬁed.
Once the reference level is set, whether below 5 S cm−1
or in the case of the above exception, in the event of sig-
niﬁcant increases in conductivity by more  than 30% of the
reference level, testing of all chemical contaminants and feed
water quality and identiﬁcation of the cause of the increase in
conductivity shall be required.
The conductivity of the treated water shall be monitored
daily, with the value, plus the reasons for any signiﬁcant
changes, being recorded.
The conductivity meter shall be calibrated at least once a
year and we  emphasise the utility of comparing it with the
TDS.
The recommended maximum concentration of aluminium
in treated water is 0.005 ppm (5 g/l). (Level of Evidence C, 2);3  6(3):e1–e52
4.2.  Highly  puriﬁed  water  for  haemodialysis
Highly puriﬁed (ultrapure) water should be used to produce
ultrapure dialysate for all types of haemodialysis. (Level of
Evidence C, 1)
4.2.1.  Microbiology
Maximum  allowable  levels  for  microbiological  purity.  In terms
of bacteriological requirements, highly puriﬁed water used
for diluting the dialysis concentrate shall contain fewer than
10 CFU/100 ml  (0.1 CFU/ml). ISO 13959. 3rd edition 2014.
Speciﬁcations  (see  Appendix  A.3.1).  In order to measure these
quantities accurately, it is necessary to analyse a sample of
highly puriﬁed water greater than 100 ml  by ﬁltration.
Action  levels  for  microbiological  purity.  We recommend that
action be taken when bacterial growth in cultures is visible
with the presence of more  than 5 CFU/100 ml  of viable aerobic
bacteria. To increase the accuracy of colony counts, the vol-
umes processed should be greater than 100 ml.  Cultures shall
be repeated with a greater volume of sample and duplicate
samples; if contamination is conﬁrmed, disinfection should
be performed to prevent the formation of bacterial bioﬁlm.
Maximum  allowable  levels  of  endotoxins.  The endotoxin con-
tent in highly puriﬁed water for haemodialysis shall not
exceed 0.03 EU/ml, measured by a sufﬁciently sensitive LAL
test. ISO 13959. 3rd edition 2014.
4.2.2.  Maximum  allowable  levels  of  chemical
contaminants  in  highly  puriﬁed  water
Highly puriﬁed water for haemodialysis shall not contain
chemical contaminant concentrations greater than those
speciﬁed for puriﬁed water for haemodialysis (Section 4.1.2
and Appendix 5).
Highly-puriﬁed water shall have maximum conductivity
of 5 S cm−1 at 25 ◦C (Appendix 5). In exceptional situations,
below 20 S cm−1 at 25 ◦C shall be allowed while the cause
of the increase in conductivity is being identiﬁed. (Level of
Evidence C, 2)
If, despite having a water treatment system with dou-
ble osmosis in series or osmosis plus an electro-deionization
system in series, conductivity of 5 S cm−1 is not reached, pro-
vided it is below 20 S cm−1 and all chemical contaminants
listed in Section 4.1.2 are within speciﬁed limits, the existing
level of conductivity shall be set as reference. In such cases,
the cause of the increase in conductivity (e.g. carbon dioxide,
pH, Na, etc.) shall be identiﬁed.
Once the reference level is set, whether below 5 S cm−1
or in the case of the above exception, in the event of sig-
niﬁcant increases in conductivity by more  than 30% of the
reference level, testing of all chemical contaminants and feed
water quality and identiﬁcation of the cause of the increase in
conductivity shall be required.The conductivity of the treated water shall be monitored
daily, with the value, plus the reasons for any signiﬁcant
changes, being recorded.
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The conductivity meter shall be calibrated at least once a
ear and we  emphasise the utility of comparing it with the
DS.
The recommended maximum concentration of aluminium
n treated water is 0.005 ppm (5 g/l). (Level of Evidence C, 2)
.3.  Design  of  a  water  treatment  system
here is no one water treatment system generic to all dialy-
is units since much depends on: chemical and bacteriological
uality of the feed water to be treated, its origin and possible
ariations in the elements dissolved in it over time; archi-
ectural constraints; quantitative needs; qualitative needs;
nancial budget; and prospective changes, both in terms of the
ater treatments themselves and new dialysis techniques.
The basic components of a water treatment system for
aemodialysis shall include a pre-treatment, where most of
he undesirable elements are removed, and treatment with
everse osmosis and some other element that would achieve
he level of puriﬁed water as part of its normal operation,
enerally a second stage of osmosis. (Level of Evidence C, 1)
Pre-treatment shall have at least one ﬁlter capable of
etaining particles in suspension or sediment, water softener
nd charcoal ﬁlter (Appendix A.2.1) designed for the charac-
eristics of the feed water supply, with duplicate equipment if
evels of the element to be removed are considered high and
ould cause serious problems in the event of failure. (Level of
vidence C, 1)
It is essential to be aware of the potential problems at later
tages as a result of poorly-designed pre-treatment; chlorine
an damage the osmosis membranes or the presence of cal-
ium can saturate them, or these elements can pass into the
istribution network and so reach the patient.
The charcoal ﬁlter shall always be installed immediately
re-RO, as close as possible, as once the water is dechlori-
ated, there is a serious risk of contamination, particularly
hen passing through other ﬁlters where the speed slows
own. (Level of Evidence C, 1)
When the feed water contains high levels of chloramines
nd other organic contaminants, or municipal, industrial or
gricultural water contamination, the use of two activated
harcoal ﬁlters in series is recommended.
Osmosis membranes shall be installed post pre-treatment,
nterposing a ﬁlter of at least 5 m,  to avoid the possibil-
ty of small charcoal particles passing through, this being an
ssential element of treatment to obtain water that meets the
uality requirements set out in the cited standards.
Installation of other elements post osmosis stage guaran-
ees better water quality. Such elements may consist of: a
econd stage of osmosis, fed by the permeate from the ﬁrst,
ith independent pumps between the two stages so that, in
he event of failure of one, the other can continue to supply
ater; or an electro-deionization system. Resin deionization
ystems are not recommended due to the high risk of contam-
nation (see Appendix A.2.1).Both electro-deionization systems and UV lamps should
lways have ultraﬁlters installed which are capable of
etaining up to the endotoxin concentration limit; electro-
eionization systems have no ﬁltering capacity and the 6(3):e1–e52 e9
bactericidal action of the UV lamps can add endotoxins to the
water.
The working tank prior to the RO shall be as small as pos-
sible. The elements post ﬁrst osmosis stage shall be installed
in such a way as to allow different conﬁgurations, so they may
be added to or complemented; a second stage of osmosis is
recommended as the best option.
Elements which can be disinfected and/or descaled shall
have the capacity to have accessories ﬁtted to allow this
function to be performed as quickly and reliably as possi-
ble: incorporated disinfectant metering pumps, programmed
wash systems, built-in programmes in the equipment itself
and sampling points.
4.4.  Water  storage  and  distribution
Once treated, the water shall be distributed directly to points
of use without storage tanks or drums, with the surplus being
returned to the treatment entry point. The piping and plumb-
ing shall be designed to prevent bacterial contamination and
be easily disinfected. (Level of Evidence C, 1)
Storage
Treated water shall not be stored as this makes it liable to con-
tamination. Storing water creates difﬁculties for disinfection.
As there are no tanks of treated water, supply of feed water
must be guaranteed, and the systems may therefore be as
follows:
– Double water supply.
– Feed water tank, which shall have the characteristics
described below and in Appendix 2 (A.2.1.1).
– Pre-treated water tank, with the same characteristics as the
above point. In the case of the pre-treated water tank, some
type of preservative or disinfectant treatment is required to
guarantee that the water does not become contaminated.
If water tanks do exist, regardless of the volume, they shall
be hermetically sealed, opaque, preferably stainless steel and
have a conical base with the water outlet at the bottom and
a 0.2 m antibacterial vent ﬁlter. The water inlet must be in
shower form.
The volume of water required to complete a day’s operation
of the haemodialysis unit shall be guaranteed.
Distribution  network
Treated water is highly inclined to acquire substances from
the elements it comes into contact with, so the distribution
network shall be made with materials that do not leach any-
thing into the water, or are not suspected of being able to do
so (copper, iron or aluminium pipes cannot be used), shall
have no dead legs, using continuous piping with no joints or
intersections, and be as short as possible. If stainless steel is
used it must be pharmaceutical grade. The pipe that feeds the
machine from the distribution network should be considered
as an integral element of the distribution network. It has to cir-
culate at a speed that minimises the risk of contamination and
bioﬁlm formation, >1 m/s, so the section has to be precisely
calculated. Unused water shall return to the water treatment
system and go through it again.
2 0 1 6
tion loop. Moreover, they avoid the risk of contamination of
the dialysate by chemical disinfectants.e10  n e f r o l o g i a. 
Joins in the plastic materials form recesses and mean sud-
den changes in the linearity of the pipe that lead to reservoirs
and disruption of the laminar ﬂow; plastic materials which do
not exhibit these drawbacks are now available on the market.
Such connections are found in elbow joints when installed to
change the direction of the pipe and in diversions to machines
and valves. When opting for a particular type of material, con-
sideration has to be given to how the connections are made,
whether welded or using adhesives, due to the possibility of
adhesives breaking down over time and leaching undesirable
elements into the water. Polymer pipes and tubes are now
available which do not have these drawbacks and resist heat
without deforming. This type of material should be used for
the distribution network (see Appendix 2). If the option is
stainless steel, it has the advantages that thermal or chem-
ical disinfection systems can be used and that it is resistant to
accidental impacts and traction. The type of welding on stain-
less steel piping is crucial to prevent subsequent corroding of
welded joints.
Dead legs must be completely avoided; outlets to machines
shall be considered as dead legs and therefore shall also be
avoided, with the emphasis on those where the pipes are
translucent. The distribution network therefore has to go to
the machine; one way to do this would be by installing a U-
bend, where the distribution network goes to the machine and
returns, then goes on to the next machine; this has the disad-
vantage that the pipe leading to the machine has the same
section as the rest of the network.
The other way to do it is with secondary rings: a primary
circuit distributes water throughout the unit and a secondary
circuit carries the water to the machine; obviously, the dimen-
sions of this secondary circuit are smaller than the primary; in
the event of breakage or blockage, only the machine connected
to it would be affected.;3  6(3):e1–e52
machines machines
The above ﬁgures show the different conﬁgurations to
ensure constant ﬂow of water to the machine: U-bend instal-
lation on the left and secondary rings on the right.
Endotoxin  retentive  ﬁlter
The distribution loop for haemodialysis water shall be ﬁt-
ted with an endotoxin ﬁlter when any of the following three
conditions exist: there is storage of treated water; double-
pass osmosis is not available; post UV lamp, if the quality
level to be achieved is of ultrapure water. The endotoxin
ﬁlter shall preferentially be ﬁtted at the beginning of the
loop.
Thermal  disinfection  system
Thermal disinfection systems are highly recommended and
should at least be installed for the treated-water distribution
loop. In conjunction with the secondary rings and the dis-
infection methods, combined with that of the haemodialysis
machines, they are the most effective way of preventing the
development of bioﬁlm in the haemodialysis water distribu-The following diagram shows a possible conﬁguration for
a water treatment system.
 1 6;3  6(3):e1–e52 e11
uration for a water treatment system.
Electro-
deionization 
system +
l filter, 
al
Osmosi s
inversa
Particle filter,
1 to 5 µm.
osis
)
Thermal
disinfection +
ET ultrafilter
UV lamp?
Reverse osmosis
(2nd stage)n e f r o l o g i a. 2 0
Pre-treatment
The following diagram shows a possible config
Water softener,
dual tank
Charcoa
du
Prefiltration
5 to 25 µm.
Entry raw water
guaranteed 24 h.
Reverse osm
(1st stageMachines
2 0 1 6e12  n e f r o l o g i a. 
4.5.  Water  treatment  systems  in  special  and  mobile
units  and  for  home  dialysis
Haemodialysis water treatment systems in Special Units, such
as high-dependency, ICU, resuscitation, etc. shall have the
same characteristics as those described above and have the
capacity to produce puriﬁed water for dialysis, as speciﬁed
in this guideline, while being subject to the same controls
and preventive measures as the other haemodialysis water
treatment systems.
Water treatment systems for home dialysis and mobile
dialysis units shall at the very least be ﬁtted with an acti-
vated charcoal ﬁlter, reverse osmosis and a 0.2  bacteria
ﬁlter. The water quality shall be monitored monthly, as spec-
iﬁed in Section 7 of this guideline, and the system shall
undergo preventive measures as described in Section 8. Once
it has been veriﬁed in an initial biochemical analysis that
the substances referred to in Section 4.1.2 are at allowable
concentrations, the conductivity of the osmosis permeate
(or product) water shall be recorded and taken as reference.
Sudden and signiﬁcant changes in conductivity shall be inves-
tigated. After periods of inactivity, if the water treatment
system is to be used again, the same methodology shall be
applied.
Home haemodialysis machines shall come with their own
endotoxin ultraﬁlter, which shall be replaced according to
manufacturer’s instructions.
5.  Concentrates  for  dialysis
The solute supply systems for the production of dialysate may
be individual,  for a single haemodialysis machine or central,
for a group of machines.
The water used to produce concentrate for dialysis shall at
the very least comply with the standards required for puriﬁed
water speciﬁed in Sections 4.1.1 and 4.1.2. (Level of Evidence
C, 1)
Ideally, it should have the level of quality required for water
for injection.
Currently, only bicarbonate shall be used as basic concen-
trate.
Its composition should be adjusted according to the clinical
situation of each patient, as is done with other factors that
inﬂuence the efﬁcacy and safety of haemodialysis.
The concentration of solutes identiﬁed on the labelling
shall be present to within a margin of ±5% or 0.1 mEq/l, with
the exception of sodium and chloride where the margin of
variability shall be ±2.5%. These margins are expressed rela-
tive to the concentration in the dialysate after dilution of the
concentrates. ISO 13958: 2009.
All the components shall be stated on the labelling along
with their quantities and level of purity. The dilution to be
used shall be stated as parts of concentrate per parts in the
ﬁnal solution (dialysate). The labelling shall state the expiry
date, which guarantees its stability.If the concentrates contain non-traditional components,
the margin of tolerance for such components shall be ±5%
of the nominal concentration of that component.;3  6(3):e1–e52
We  recommend that manufacturers should provide chem-
ical and microbiological quality certiﬁcates for the batches of
concentrates supplied.
The containers, including caps and stoppers, shall be made
of materials that do not interact with the concentrate, thereby
contaminating it, and shall be airtight.
5.1.  Individual  concentrates
Acid  concentrate
An acidic solution of concentrated salts which may contain
dextrose. It is diluted with puriﬁed water and the bicarbonate
concentrate to produce dialysate. In general, most patients
can be dialysed with standardised ion concentrations in acid
concentrate, although the type of concentrate should be indi-
vidualised for each patient. (Level of Evidence B, 1)
Bicarbonate  concentrate
A concentrated solution of sodium bicarbonate which is
diluted with puriﬁed water and the acid concentrate to pro-
duce dialysate. Some bicarbonate concentrates also contain
sodium chloride. (Level of Evidence C, 1)
Current recommendations are that bicarbonate in powder
form should be used for producing dialysate. (Level of Evi-
dence C, 1)
Surplus bicarbonate from dialysis shall be discarded. (see
Appendix A.2.2). (Level of Evidence C, 2)
Bicarbonate  and  citrate  concentrates
The acid concentrate usually contains acetic acid as stabiliser
for the mixture with bicarbonate. It is used at concentrations
of 3–10 mmol/l. Such concentrations cause transfer of acetate
to the patient during HD, raising blood acetate concentrations.
Exposure to acetate is increased in on-line haemodiaﬁltra-
tion techniques. The increase in blood acetate levels has
been associated with a number of undesirable effects in the
patient and there have been efforts for some considerable
time now to ﬁnd other acids to use as stabilising agents for
dialysate. Citrate dialysate is a new alternative to using acetate
as acidifying agent. Citrate is a calcium-chelating agent that
is also used for its anticoagulant effect as it reduces cal-
cium ion concentrations. A number of long-term beneﬁcial
effects have been described in relation to citrate, including
reduced thrombogenicity, improvement in clearance, inﬂam-
mation, nutrition and tolerance, and improved control of
acid-base balance leading to less pre-dialysis acidosis. More
scientiﬁc evidence is required to justify switching from acetate
to citrate in all haemodialysis.Citrate concentrates suitable for
different machines are currently available on the market,
without acetate or with a mixture of the two  stabilising
agents.
Forms  of  presentation
Acid concentrate comes in:• Container
• Bag
• Dry cartridge of sodium chloride + bag of ions
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 Bulk delivered concentrate (see Section 5.2)
Under this classiﬁcation, we have presentations that facil-
tate individualisation of treatment, others that do not and
hose with which individualisation is impossible. The bulk
ystem makes individualising treatment difﬁcult or even
mpossible in terms of the concentration of solutes in the
ialysate.
The dry cartridges of sodium chloride plus ion bag fully
acilitate individualisation without increasing the storage
pace required; since they are single-use, they are also very
afe.
The containers of concentrate allow individualisation, but
n increased number of formulas have to be stored, meaning
ore  space is required, and they can be less safe.
Bags allow individualisation, take up less space and are
referable in terms of safety since they are single-use and
annot be reﬁlled.
Bicarbonate concentrate comes in dry cartridges or con-
ainers:
We recommend that containers of bicarbonate shall no
onger be used, replacing them with bicarbonate powder car-
ridges. (Level of Evidence C, 2)
.2.  Central  concentrate  systems
ndividual concentrate systems are preferable to central
oncentrate systems from the point of view of safety and indi-
idualisation, but they are more expensive and create greater
roblems in terms of storage and waste. The central produc-
ion systems for bicarbonate concentrate are the most liable
o microbiological contamination and are therefore not rec-
mmended. (Level of Evidence C, 1)
In situ central concentrate generator system shall be
esigned to include a source of puriﬁed water, easy draining
nd grounding for electrostatic discharge. They shall be made
ith materials that do not cause contamination to water,
re non-corrosive and prevent the formation of mould and
lgae.
Tanks used to store the mixture shall be emptied and
leaned of debris and residue before using other concen-
rate baths in order to prevent cross-contamination between
he different concentrate formulas. Use of additives in the
cid is prohibited, as they can distort the composition of the
ialysate; only potassium or calcium may be added and this
hall always be indicated on the labelling, stating the ﬁnal
oncentration.
Sodium bicarbonate tanks are not recommended but, if
sed, in addition to meeting the above characteristics, the
alls and bottom shall be cleaned and disinfected. Sodium
icarbonate may be used in liquid or powder form. In both
ases, but particularly with powder, the concentration shall
e monitored prior to distribution; generally between 34 mEq/l
nd 40.8 mEq/l.
The other mode consists of bulk delivered concentrate.
hey come in large containers or cisterns and are then
elivered directly to the dialysis machine. The installation
hall allow sufﬁcient space and adequate access for that
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The distribution network for concentrates shall be colour-
coded, with the outside of the pipes painted red for those
delivering acid mixture and blue for sodium bicarbonate. We
also recommend that the tanks should be translucent so that
levels are always visible; level-indicator tubes should not be
used, especially not in the case of bicarbonate, due to the risk
of bacterial growth.
The acid concentrate distribution systems and, if appli-
cable, the preparation tank, must have programmes for
disinfection, descaling and cleaning of the installation, and
this shall be done at regular intervals, at least annually, to
guarantee optimal microbiological quality of the system. See
Section 8.2.
5.3.  Microbiology
The maximum allowable levels for microbiological contami-
nation shall be identical to the purity level for puriﬁed water
at the end of valid shelf-life. Microbiological contamination
levels for concentrates are the same as for puriﬁed water (see
Section 4.1). (Level of Evidence C, 2)
Once opened, containers of individual bicarbonate concen-
trate shall be handled with care to prevent further bacterial
contamination. Previously-opened containers shall not be re-
used; any fraction left over from a dialysis session shall be
discarded. (Level of Evidence C, 2)
Concentrates which have undergone some type of sterili-
sation or disinfection procedure shall be preferred.
5.4.  Chemical  contaminants
The grade of purity of the elements used for preparation of
the concentrates shall be high and comply with the corre-
sponding standards. Puriﬁed water shall be used to prepare
concentrates. (Level of Evidence C, 1)
The manufacturer should specify the requirements regard-
ing chemical contaminant concentrations for puriﬁed water.
In the United States, Chemical Grades are regulated by the
USP/National Formulary. The salts used in the preparation of
the concentrates can be a source of contamination and metal
poisoning for the patient (see also ISO 13958: 2009).
6.  Dialysate  quality
Ultrapure  dialysate  quality
We  recommend that ultrapure dialysate shall be used for all
types of haemodialysis, haemodiaﬁltration and haemoﬁltra-
tion.
6.1.  Maximum  levels  of  microbiological  contamination
in dialysate
Maximum allowable contamination in ultrapure dialysate is
0.1 CFU/ml for bacteria and 0.03 EU/ml for endotoxins. ISO
1163: 2009.
The testing method is the same as for highly puriﬁed water
for haemodialysis.
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To minimise inﬂammation in patients on haemodialy-
sis, all dialysis units shall use ultrapure dialysate for all
types of haemodialysis. The routine use of ultrapure dialysate
requires the ﬁtting of speciﬁc ultraﬁlters in the dialysate cir-
cuit. (Level of Evidence B, 1) The ultraﬁlters shall be used and
replaced according to the manufacturer’s instructions.There
shall be a protocol for action when dialysate contamination is
demonstrated in a haemodialysis machine. The action mea-
sures shall include withdrawal of the machine, replacement
of the ET ultraﬁlter and general revision of the machine’s
operation. Full disinfection and descaling shall be carried out,
including the point of connection to the loop, the tubing, the
internal hydraulic circuit and the connectors.
6.2.  Maximum  concentrations  of  chemical
contaminants
The speciﬁcations are the same as for puriﬁed and highly
puriﬁed water (Sections 4.1.2 and 4.2 respectively), except
for the solutes used for the concentrates and the resulting
conductivity. (Level of Evidence B, 1)
6.3.  Dialysate  preparation
A haemodialysis machine is a medical device designed to
mix  the concentrated electrolyte solutions or powder with the
treated water to an electrolyte concentration, pH and tem-
perature determined by medical prescription. The dialysate
water shall be suitably degassed. The amount of electrolytes
diluted in the water is monitored by dual systems, by measur-
ing electrical conductivity and/or the pH of the ﬁnal solution
(pH meter). The temperature is monitored by thermometer.
Before being delivered to the dialyser, the dialysate has to have
passed through at least one ultraﬁlter. Hydraulic circuits in the
machines, with no dead spaces, are preferred. A machine’s
entire hydraulic circuit has to have an automated and pro-
grammable disinfection system.
The conductivity and composition of the dialysate shall be
exactly as prescribed by the doctor.
Regular use of ultrapure dialysate over the long-term helps
prevent or delay a number of the complications associated
with haemodialysis. (Level of evidence A, 1)
7.  Quality  control
The chemical and microbiological purity of water and HD
ﬂuid shall be monitored regularly and the results recorded.
There shall be protocols in place with details of the proce-
dures to be followed in the event that the performance limits
or prescribed limits are exceeded. These protocols shall even
contemplate the temporary closure of the dialysis unit when
breach of the required safety limits reaches unacceptable lev-
els. (Level of evidence C, 1);3  6(3):e1–e52
7.1.  Technical  monitoring  of  the  process  components
Daily monitoring of key elements or parameters, which is
easy and quick to oversee, helps ensure the proper operation
of the various components of the water treatment system; it
can also prevent an emerging problem in one component from
developing and causing serious repercussions on some other
part of the system, and ultimately affecting the quality of the
treated water. Both feed water and treated water shall there-
fore be tested daily for the following: Free and total chlorine
(chloramine) levels; hardness; and conductivity. At the same
time, the pressures and ﬂow rates in the different components
of the water treatment and distribution equipment shall be
monitored. (Level of Evidence C, 1)
Current mandatory requirements regarding the quality of
water for haemodialysis mean that all the elements involved
in producing this water need to be more  strictly monitored. It
is essential to keep an accurate record of all tests and proce-
dures performed on the water treatment system and to follow
the prescribed maintenance protocols for each element in the
system. A protocol shall be drawn up in advance detailing the
procedures to be followed in the event that faults are detected.
The necessary procedures will depend on the particular water
treatment system, the staff involved, characteristics of the
unit, etc. so the protocol shall be written individually for each
haemodialysis unit.
The technical and user manuals must be available for the
different items of equipment. The staff responsible for moni-
toring shall receive sufﬁcient training and information on all
elements of the water treatment system and have the appro-
priate accreditation.
Routine testing can vary depending on the equipment and
the quality of the water to be treated; in some cases it may
be necessary to perform tests more  frequently, especially in
the validation or commissioning phase. In this phase, testing
should be done daily, at least at the start of dialysis sessions
and on completion of the last of the day, to check the effective-
ness of the ﬁlter elements, both to verify the correct volume
of the these elements and the programming of regeneration
and/or backwash steps.
The frequency of monitoring of the water treatment system
is based on two levels, for both technical and analytical moni-
toring: the ﬁrst level, during the validation of a new treatment
plant, refurbishment of an old facility or after a contamination
requiring corrective action; the second level, during mainte-
nance, day-to-day management of the treatment system, after
the end of the validation period. The tests to be performed can
be classiﬁed into three areas: technical; chemical; and micro-
biological.
The following table is intended as an aid to organising the
tests to be performed. It should be used to complement the
testing instructions provided by the equipment manufactur-
ers; although, given the context in which their equipment is
used, they can at times be a bit “relaxed” about the frequency.
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E onthly testing and
procedures
Comments
F Certain automatic actions of
the treatment system, essen-
tially self-cleaning, cause vari-
ations in the normal pressures.
E easure chlorine –
hloramines, hard-
ess and conductivity.
Increase testing frequency if
changes in conditions are sus-
pected: drought, irrigation in
the proximity, work on cis-
terns, etc. Any change can
affect elements of the treat-
ment system or the ﬁnal qual-
ity and make some type of
modiﬁcation necessary. Com-
pliance with Royal Decrees
140/2003 and 865/2003
P  ﬁlters are auto-
ashable, verify
peration of the wash
ycle.
The operation or condition
of subsequent elements may
indicate the proper func-
tioning of the preﬁlter. Make
changes to the ﬁlter element
following the manufacturer’s
or installer’s instructions.
W heck consumption
f salt, the various
tages of regenera-
on, condition and
peration of the con-
ol elements: ﬂow
eters; programmer;
tc.
Alterations in conductivity
pre-osmosis and decreased
reject and permeate ﬂow rates
may be indicative of faults in
the water softeners. Do  not
prolong the life of the resins
beyond that recommended by
the manufacturer. There are
speciﬁc devices for monitoring
hardness on-line.
C heck operation of
e wash cycle -
xpansion. Condition
f automatic con-
ol elements. Test
ubsequent ﬁlter.
Replace charcoal at least once
a year. If there are two  char-
coal ﬁlters in series or parallel,
it shall be possible to perform
measurements independently.
The condition of the subse-
quent ﬁlter is indicative of
the operation of the charcoal
ﬁlters.n e f r o l o g i a. 2 0
lement Daily testing M
low rates and
pressures (pres-
sure gauges)
Check through-
out the course
of the treatment
for any abnor-
mal  variations in
pressure.
ntry of feed water Pressure M
c
n
reﬁltration (sand,
iron-retention
ﬁlters, etc.)
Pressure differ-
ence between
input/output
and state of the
programmer.
If
w
o
c
ater softener Test hardness at
output and record,
indicating the
softener active at
that time and the
remaining vol-
ume  for the next
regeneration. State
of the salt (brine)
tank.
C
o
s
ti
o
tr
m
e
harcoal ﬁlter
(dechlorinator)
Measure free and
total chlorine
(chloramines) at
the output of each
charcoal ﬁlter at
maximum con-
sumption. Should
be done once
per shift if there
are no treated
water tanks. If
there are treated
C
th
e
o
tr
swater tanks, also
measure post
tanks.
2 0 1 6;3  6(3):e1–e52
onthly testing and
procedures
Comments
st. Microbiolog-
testing pre-RO
r disinfection,
the dechlori-
 outlet to the
inlet to the
equipment, if
ted contamina-
or malfunction
 RO is detected.
nding on the
s, the frequency
e extended.
This element, from the dechlo-
rinator outlet to the RO equip-
ment, is susceptible to growth
of microorganisms of various
kinds in the absence of chlo-
rine; this can have a major
impact on the ﬁnal microbi-
ological quality of the water,
hence the need for prevention
and/or monitoring.
 operation of
atic actions
isible in usual
tion such as
 operation,
rinsing of mem-
s, etc. and
ment con-
and protection
nts.
Perform disinfection and
descaling of the membrane
according to manufacturer’s
speciﬁcations. Respect ﬂow
rates and pressures speciﬁed
by manufacturer; in the event
of unexpected variations, a
detailed analysis (chemical,
bacteriological, endotoxins,
SDI) should be carried out
of elements pre and post RO
equipment.
thly or other
cy of testing and
rocedures
Comments
operation alarm
easurement sys-
Increase in conductivity (or reduction in
resistance) or change in the pH suggests
saturation or malfunction of some ele-
ment, resulting in high risk of contami-
nation. The alarm should be adjusted to
very low levels to allow the defect to be
corrected (≈1 Mohms/cm = 1 S)
ve microbiologi-
 endotoxin anal-
ould be carried
he feed inlet and
o check for effec-
s, regardless of
lyses performed
rest of the treat-
High risk of loss of pressure due to
clogging. Respect the maximum useful
life stated by the manufacturer (time or
clogging). Whenever replacing, carry out
disinfection of the corresponding part of
the hydraulic circuit. Rupture carries the
risk of massive release of retained ele-
ments, e.g. endotoxins.e16  n e f r o l o g i a. 
Element Daily testing M
Microﬁltration
prior to reverse
osmosis equip-
ment
Pressure differ-
ence between
inlet and outlet.
SDI te
ical 
and/o
from 
nator
feed 
RO 
repea
tion 
of the
Depe
result
can b
Reverse osmosis
equipment
Conductivity at
inlet and outlet
or total dissolved
solids (TDS).
Pressures and
ﬂow rates. Ion
rejection. Check
programmer
(alarm history,
overview).
Check
autom
not v
opera
night
auto-
brane
equip
trol 
eleme
Element Daily testing Mon
frequen
p
Electro-
deionization
system
Conductivity or resis-
tance, pH.
Verify 
and m
tems.
Ultraﬁlters Inlet and outlet pres-
sure, input, outlet and
rejection ﬂow rates.
Exclusi
cal and
ysis sh
out at t
outlet t
tivenes
the ana
in the 
ment system
Ultraviolet (UV)
lamp
Light intensity 16–30
milliwatt-s/cm2.
Change the lamp according to the man-
ufacturer’s technical speciﬁcations.
 1 6;3  6(3):e1–e52 e17
E thly or other
y of testing and
ocedures
Comments
D disinfectant
hen used.
Set disinfection schedule based on the
characteristics and length of the net-
work, product water quality, type of
disinfection (thermal, chemical). Every
disinfection shall be recorded along with
the reasons (protocol or contamination).
The outlet to a non-working machine
shall be considered a dead leg.
T drive pumps
tic systems).
operation of
d alarms.
If for treated water, disinfect with the
distribution network. Change vent ﬁlter
according to speciﬁcations. If for raw or
pretreated water, chlorine/chloramine
levels have to be monitored to prevent
contamination. Check for presence of
silt and general cleanliness.
H ted at least
ally. Strictly
ructions for
oring, espe-
erted in the
eck that the
 have physi-
nto (Floating
se last one”
s from dial-
tenance and
Haemodialysis machines, in effect, act
as dead legs and can alter water quality
and therefore that of the dialysate and,
in extreme, cases, affect the entire unit.
In speciﬁc cases (e.g. repeated contam-
ination), microbiological monitoring of
the drains may be necessary; be aware
that these points are easily contami-
nated from the external environment,
and results must therefore be inter-
preted based on that premise.
7
d
M
f
fn e f r o l o g i a. 2 0
lement Daily testing Mon
frequenc
pr
istribution net-
work (including
water intake
haemodialysis
machines)
Check pressure at the
inlet and outlet of the
distribution loop. Circu-
late water through dead
legs if any. Measure chlo-
rine/chloramines when
there are treated-water
tanks.
Monitor 
rinses w
anks If for treated water,
measure chlorine/
chloramine levels and
hardness in distribution
network.
Switch 
(automa
Check 
levels an
aemodialysis
machines
Machines in reserve shall be disinfec
once a week and rotated periodic
comply with the manufacturer’s inst
disinfection, maintenance and monit
cially those relating to ultraﬁlters ins
dialysate delivery to the dialyser. Ch
waste pipes from the machines do not
cal contact with the piping they drain i
drain or contactless drain); clean the
regularly to avoid deposit of substance
ysis. Each machine shall have a main
incidents record.
.2.  Analytical  monitoring  of  dialysis  water  and
ialysate  quality
onitoring of the water system should be performed at dif-
erent points of the dialysate production process, at different
requencies according to the circumstances:
Validation period of a new water treatment system follow-
ing installation or a major refurbishment, or after having
detected high levels of contamination which required correc-
tive action. What exactly constitutes a major refurbishment
or corrective action can be difﬁcult to deﬁne; the following
scenarios should be taken as a guide:
– Any change affecting designation as “Medical Device”
of any of the equipment, according to Royal Decree
1591/2009.
– Changes in feed water quality resulting in installation
or modiﬁcation of any part of the pre-treatment and/or
osmosis equipment.
– Repeated contaminations which, in addition to the appro-
priate disinfection, require modiﬁcation of any part of the
installation due to being identiﬁed as possible source of
the problem.
The validation period for a water treatment system refur-
bishment can be compatible with the operation of thehaemodialysis unit. After the refurbishment, a full disinfec-
tion shall be carried out and the proper operation of all the
elements of the water treatment system and that the con-
ductivity of the treated water is <5 S/cm−1 shall be veriﬁed.
At the same time, the analytical tests speciﬁed in this section
shall be performed.
Maintenance period: Maintenance of a system in routine
operation.
7.2.1.  Microbiological
Microbiological monitoring of puriﬁed and highly puriﬁed
water shall be done weekly for the ﬁrst month after commis-
sioning of the unit (validation phase). If any of the cultures
or ET are positive, the necessary corrective measures shall
be taken and the validation period extended for a further
month. Subsequently, and during the maintenance phase,
monitoring shall be carried out at least once a month. (Level
of Evidence C, 2)
Testing for endotoxin levels shall be performed monthly
in both the validation and maintenance periods. (Level of Evi-
dence C, 2)
Each centre shall establish a written protocol setting the
frequency, method and responsibilities for these tests. Opera-
tional units shall test the quality of the dialysis water at least
monthly, using the culture methodology and sampling points
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speciﬁed in this guideline. For more  details, see Appendix
A.3.1.
Sampling points for microbiological cultures: In the validation
period, samples shall be collected of the following: feed water;
softened water; the water immediately pre-RO equipment; the
treated water immediately post-RO; water from the end of the
distribution loop and from at least 10% of the water intakes for
the machines (HD stations); and the dialysate on entry into the
dialyser in a minimum of 10% of the machines.
Microbiological testing of the water shall not be performed
within the ﬁrst 24 hours following disinfection.
In the maintenance period, samples of the treated water
shall be collected for cultures and ET from the ﬁrst point and
last point of the loop, post osmosis and at 10% of the connec-
tion points to the machines. After 12 months, samples shall
have been taken from connection points to all the machines,
including unused connection points. Samples of dialysis ﬂuid
shall be taken for cultures and ET pre-dialyser in 10% of the
machines. After 12 months, all machines, including reserves,
shall have been tested. (Level of Evidence C, 2)
In the maintenance period, it is not necessary to take sam-
ples of feed water or samples from intermediate points of
pre-treatment, unless contamination is detected or alteration
in the quality of the treated water suspected.
Sampling should be carried out post charcoal ﬁlter and pre
reverse osmosis equipment, especially if there is no speciﬁc
protocol for regular disinfection of this section.
For machines, the same criteria shall be followed as in the
validation period, such that all machines shall undergo micro-
biological testing at least every 12 months.
In facilities with storage tanks for treated water, samples
shall also be taken pre and post tank, generally coinciding with
the outlet from the osmosis equipment and the beginning of
the distribution loop respectively.
In the event of environmental microbiological contamina-
tion of the haemodialysis unit, additional samples may be
taken of the drainage from the machines, but it is important
to be aware that this section of piping is exposed to external
contamination, because of its proximity to or direct contact
with the drainage system.
In home haemodialysis with production of dialysate,
microbiological monitoring should be done monthly, possibly
alternating a water sample with a dialysate sample.
There are local regulations and guidelines which are
stricter in terms of number of samples and testing frequency.
7.2.2.  Chemical
Conductivity, corrected to 25 ◦C, shall be measured continu-
ously in the permeate from the osmosis. The reading shall
be visible and connected to an alarm system to alert any
changes.
Water hardness, free chlorine and total chlorine (chlo-
ramines) tests shall be performed daily. The sampling points
are speciﬁed in Section 7.1. They should preferably be per-
formed prior to the ﬁrst haemodialysis session of the day.
Testing for all chemical contaminants speciﬁed in Section
5.2 (maximum levels of chemical contaminants) shall be per-
formed twice in the validation period and annually in the
maintenance phase. Aluminium shall be monitored every six
months.;3  6(3):e1–e52
The sample for the determination of chemical contami-
nants shall be obtained from one of the water connection
points to the machines.
Water hardness shall be tested daily using a titration
method or permanently with an alarmed instrument. Regen-
eration shall be adapted to the cycle of volume, salt activity,
capacity of the resins and the water hardness; the programmer
status shall be checked daily.
If the disinfection system for potable water uses chlo-
ramines, concentrations in the water shall be determined
indirectly by measuring the free and total chlorine and cal-
culating the difference.
There are local regulations and guidelines which are
stricter in terms of number of samples and testing frequency.
8.  Methods  for  correction  and  prevention
8.1.  Methods  for  correction  and  prevention  for  water
The procedures for disinfection, descaling and detergent
action are an integral part of the maintenance system for the
water plant and distribution network. The frequency, type of
disinfection and descaling (heat, chemical, mixed) and peri-
odic changes in their components (ﬁlters, resins, membranes,
ultraviolet lamps) shall be according to the manufacturers’
instructions and based on the results of the microbiological
tests. (Level of Evidence C, 1)
The aim of maintenance of a dialysis-water treatment sys-
tem and dialysis machines is to prevent contamination, not
treat it. Methodology based on treating contamination is not
acceptable. Prevention is based on scheduled disinfections,
with frequency and type depending on the design of the water
treatment system and the dialysis machines. Analytical tests
are used to verify proper operation, not to indicate when dis-
infection is necessary. (Level of Evidence C, 1)
Automated disinfection systems should be used in the
treated-water distribution circuit; they may operate by heat
or chemicals, or be mixed, and should include an endotoxin
ﬁlter. Automated systems make  it easier and safer to maintain
microbiological standards. Frequent automatic programming
helps prevent contamination. We recommend programmable
thermal disinfection of the distribution loop for maintenance
of highly puriﬁed water production. (Level of Evidence C, 1)
It is important that the construction materials for the cir-
cuit do not contribute to chemical contamination of the water
(aluminium, zinc, copper, etc.) and are compatible with the
different disinfectants to be used in maintenance. The most
suitable materials for a water distribution circuit are: stain-
less steel (at least SS316); acrylonitrile butadiene styrene;
cross-linked polyethylene (PEX-A); polypropylene; polyvinyl
ﬂuoride and polyvinyl chloride and new materials such as
PVDF (polyvinylidene ﬂuoride). Whichever the case, they shall
be labelled for sanitary use and CE marked. Materials resistant
to high temperatures should always be used as preference.
Stainless steel allows thermal and chemical disinfection,
but it is important to use an approved steel grade and also
that the welded joints are not subject to corrosion.
Preventive disinfection can affect the tanks, pre-treatment,
treatment, loop and machines.
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Cleaning of the haemodialysis room and drains is another
spect to be considered.
In view of the above, outlines of preventive disinfection and
orrective disinfection are provided below. Minimum preven-
ive disinfection would be as follows:
Disinfection of the loop; shall be done at least every four
months. If microbiological contamination is detected, cor-
rective disinfection shall be performed and the frequency of
the preventive disinfections increased.
In the case of an automatic heat disinfection system, rec-
ommended to produce highly puriﬁed water, this shall be
programmed to run at least once or twice a week.
Full disinfection, which includes pre-treatment, shall be
done at least annually, to coincide with replacement of the
activated charcoal.
Ideally, the disinfection of the loop should be done in con-
junction with disinfection of the machines.
When there are reservoir tanks of treated water, disinfection
of the loop shall include the tanks.
According to the requirements of the ISO standard (ISO DIS
3500), the circuit of the reverse osmosis unit shall be disin-
ected regularly. This includes:
 The reverse osmosis membrane and all the internal compo-
nents of the RO circuit
 The distribution pipes
 The post-RO tanks and ﬁlters
.2.  Corrective  actions  for  concentrates
he individual concentrates shall meet the labelling speciﬁ-
ations. If they are found to be contaminated, they shall be
ejected and exchanged for a non-contaminated batch and
he incident reported.
In central systems, the descaling and disinfection and
ther forms of prevention and treatment shall be done as
peciﬁed by the supplier. We recommend that disinfection
hall be carried out at least every 12 months and bacterio-
ogical analysis tests performed 3 days prior to disinfection.
If microbial contamination of dialysate is detected while
evels in water are in the acceptable range, the concentrate
hall be suspected as source of contamination and the appro-
riate cultures performed.
.3.  Corrective  actions  for  dialysate
aintenance and periodic disinfection of the haemodialysis
achines are mandatory for preventing proliferation of bac-
eria and bioﬁlm formation in the hydraulic circuit. In order to
revent bacterial contamination and the transmission of viral
iseases, we  recommend that they shall be disinfected after
ach haemodialysis session. (Level of Evidence B, 1)
Before commencing any haemodialysis session, it is
andatory that the composition of the dialysate is exact and
hat any disinfectant has been completely rinsed out.
The type of disinfection and the regimen shall be as recom-
ended by the manufacturer of the machine. They shall be
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all staff involved in the process informed. Disinfection and
rinsing shall be recorded along with the name of the person
responsible.
The machine tubing and all elements in the hydraulic cir-
cuit which are not covered by the automatic disinfection of
the machine shall be disinfected at least annually.
Once disinfection of any element of the dialysate pro-
duction, water treatment, centralised concentrate preparation
and dialysis machines is completed, appropriate rinsing shall
be performed followed by testing for residual disinfectant. See
Appendix 4.
9.  Dialysate  quality  management
9.1.  Staff
The success of the water and dialysate quality management
process lies in the collaboration of all staff working in the
dialysis unit (nephrologists, nurses, technicians, analysts,
microbiologists and prevention specialists) and adherence to
procedures; all those involved shall strictly follow the estab-
lished protocols.
There shall be at least one person responsible for quality
management of the water treatment system.
The responsibility may fall to the person in charge of the
maintenance and servicing of the water treatment unit. If this
is contracted externally, it shall be carried out jointly together
with a designated senior member of the haemodialysis unit
staff. The staff responsible for quality management should be
speciﬁcally trained in the use of the water treatment equip-
ment, the proper methodology for the tests and corrective
actions.
The staff responsible shall be subject to periodic audits to
conﬁrm their competency.
The procedures shall include the temporary closure of the
dialysis unit if contaminant safety limits are exceeded.
9.2.  Resources  required
The dialysate quality control protocol shall be properly speci-
ﬁed and followed by those responsible. The means for proper
operation shall be as speciﬁed in each of the sections in this
guideline. The speciﬁed human and material resources shall
be provided by the company or the public administrative body
responsible for the care of the patients on haemodialysis. The
company or institution owner of the haemodialysis unit shall
be responsible for providing the means necessary for proper
operation.
Dialysis shall not be performed without water ﬁltered by
activated charcoal and subjected to osmosis.
9.3.  Documentation
There shall be a paged record book or secure, controlled-
access computerised form where all actions taken concerning
water treatment shall be recorded, as speciﬁed in this guide-
line. The person in charge of the water treatment system shall
be responsible for completing it.
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to a chronic inﬂammatory state which, over time, nega-
tively affects patients’ health in many  different ways.17–28
Our present objective should be to achieve an ultra-
pure haemodialysis ﬂuid which only contains water and
the necessary components. Dialysate plays a key role in
the biocompatibility of HD; hence the importance of its
quality.18,21,26,27,29
However, it is difﬁcult to determine where to establish
the cut-off points for potentially toxic substances in
dialysate. The AAMI sets the limits according to the tox-
icity of the particular substances.30 In the ﬁrst category,
they include the solutes added to the dialysate, such as
Na, Ca, Mg and K and set levels that do not affect the
ﬁnal concentration in the dialysate. In the second cate-
gory, they include substances regulated by the standards
for potable water, such as arsenic, cadmium, lead, etc.
(see Appendix 5), setting the limit at 10% of that. Included
in the third category are substances with particular sig-
niﬁcance for patients on dialysis in terms of poisoning,
such as chloramines or aluminium, setting the limits for
their concentrations according to the values reported as
toxic in the literature.30 Since 1981, new potential toxic
substances have steadily been discovered, either from
the water, components of the water treatment system,
concentrates or machines, resulting in new elements
having to be added to the list of those to be removed and
monitored.31 More attention is also now given to bac-
terial contamination and the potential consequence of
that, endotoxaemia. This guideline has taken as max-
imum limits those set by the ISO 2014, complemented
on occasion by the European Pharmacopoeia standards.
This is obviously a process under constant review, depen-
dant on the discovery of new toxic substances or new
levels of toxicity, and we  should therefore highlight three
possible changes for the future.
The ﬁrst refers to aluminium concentrations. The alu-
minium in water is present as ions associated with salts
and in colloidal form, bound to organic material. Depend-
ing on the pH, the ion form can vary from a trivalent
cation to a complex anion. Softeners only remove the
cation forms. Colloidal aluminium is not removed by
deionisers (DI); the only process with the capacity to
remove it is reverse osmosis (RO). Aluminium is some-
times added to water as ﬂocculant for organic matter, so
it can be in very high concentrations. In such situations,
the only way to achieve optimal levels in the dialysate is
to work in series with two RO.1
We  know that the balance of aluminium during dialysis
is established between free or ultraﬁltrable plasma alu-
minium, 5–10% of the total, and the aluminium in the
dialysate and, if we want to create a distinct negative
balance, maintaining Al concentrations in blood below
30–50 g/l, we have to maintain the concentrations in
dialysate below 5 g/l.32 These days, we want HD patients
to maintain aluminium levels below 20 g/l.e20  n e f r o l o g i a. 
The results on the chemical and bacteriological purity
of the dialysis water shall be monitored periodically and
regularly, and those results shall be duly recorded. Well-
documented procedures shall be in place informing of the
steps to be followed in the event that the limits are exceeded.
Corrective actions shall also be recorded.
9.4.  Responsibilities
Each person involved in managing the production of dialysate
is responsible for their own duties.
Ultimate responsibility for the dialysis ﬂuid being as per
speciﬁcations, both in terms of chemical composition and
microbial contamination, and for it meeting the standards
described herein, is the senior clinician in charge or the head
of the dialysis unit.
The public body, public/private partnership or private
company responsible for the healthcare of the patients on
haemodialysis, shall ensure all necessary means to deliver
this standard of quality.
The procedures shall include the temporary closure of the
dialysis unit if contaminant safety limits are exceeded.
10.  Rationale  for  the  development  and
provisions  of  this  guidelines  references
10.1.  Purity  and  quality  of  water  for  haemodialysis
Over 96% of the 90–240 litres per session of dialy-
sis ﬂuid (dialysate) that comes into contact with the
patient through the dialyser is made up of haemodialysis
(HD) water. Contaminants in the water can be trans-
ferred to the patient and lead to accumulation in large
quantities. Added to that is the fact that renal failure
prevents the patient from being able to eliminate accu-
mulated contaminants, leading to actual poisoning. The
medical literature contains many  reports of acute and
chronic poisoning in haemodialysis patients caused by
water contamination and leading to signiﬁcant morbid-
ity and mortality.1–17 As water is the main component of
dialysate and the most difﬁcult to standardise, it is one
whose production must be most closely controlled.
In the early days of haemodialysis as treatment tech-
nique for chronic kidney failure, the aim of water
treatment was to prevent hard water syndrome and
bacterial contamination.5 Later, difﬁcult-to-remove con-
taminants had to be tackled, such as certain metals –
aluminium poisoning for example causes encephalopa-
thy and osteomalacia1,2 – or chloramines, which can
cause outbreaks of anaemia in haemodialysis units due
to haemolysis.3,8 Meanwhile, cases have continued to be
reported of poisoning by different contaminants.10–16
More  recently, the focus for concern has moved to an area
bordering between clinical and subclinical repercussions
which includes the problem of pyrogens/endotoxins. We
now know that although not all our patients suffer pyro-
genic reactions, many  are exposed to endotoxins, leading
Measuring substances such as aluminium requires a pre-
cise methodology, the use of non-metallic needles and
special tubes, and preventing contamination of any kind.
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The procedure used is atomic absorption spectropho-
tometry, in graphite furnace to avoid contamination. In
view of aluminium’s special characteristics, if the alu-
minium concentrations in water are good, i.e. <5 g/l, and
water conductivity is below 5 S/cm, we can presume
that the water’s ion properties are also acceptable and
that the other anions and cations will also be as required.
Possibly the exception to this rule is water with very high
content in mercury or iron, in which case ﬂocculation
and chelation systems shall be required to remove these
elements.
The second subject for discussion is the allowable con-
centration of chloramines. Chlorine is added to potable
water as a bactericide because it is a strong oxidis-
ing agent. This function is performed by free chlorine,
which quickly dissolves. The way to maintain stable
levels of free chlorine is the formation of chloramines,
mono-, di- and trichloride nitrogen compounds, which
release the chlorine slowly. Chloramines are able to
pass through most water treatment systems, including
reverse osmosis.33,34 There are essentially two systems
for removing them from water: reaction with activated
charcoal; and reaction with sodium bisulﬁte. The choice
of one system or another depends on the characteris-
tics of the water to be treated and the pH these reactions
cause as, depending on the type of membrane, they will
affect the performance of the reverse osmosis system.
For the production of puriﬁed water for HD, activated
charcoal is recommended31,34,35 as it is easier to main-
tain, it is safer and it has a broader spectrum of retention,
although proper maintenance and regular renewal is
essential. If small amounts of chloramines cross into the
blood, they cause oxidant effects, the most important
being haemolysis. Chloramines are difﬁcult to measure
so concentrations are usually estimated as the differ-
ence between total chlorine and free chlorine, although
this method lacks sensitivity. When measured using
this method, the allowable levels should be less than
0.06 mg/l for total chlorine and 0.05 mg/l for chloramines,
not 0.1 ml/l as the limit currently stands.31,35,36 Published
data35,37 show higher rates of anaemia associated with
chloramine levels around 0.1 ppm. An alternative solu-
tion which is used in North America is placing two
activated charcoal ﬁlters in series and doing the deter-
minations between the two.
The third point for discussion is how to test for pyrogenic
substances; those which trigger inﬂammation in patients
on haemodialysis. The standard method is the LAL
test. Should we  be using more  sensitive tests to detect
endotoxins (ET) or should we be looking for simple, stan-
dardised tests for ET and other pyrogenic substances?
This subject will be discussed later.
The complexity and cost of the water treatment system
therefore differs signiﬁcantly according to the desired
degree of purity. Two different grades of purity can be
used for the water in haemodialysis: puriﬁed and highly
puriﬁed (ultrapure). Puriﬁed water is the basic form
of treated water, valid for conventional haemodialysis.
Microbiological contamination of puriﬁed water must
comply with the recommendations of the European Phar-
macopoeia: bacterial count less than 100 CFU/ml; and
less than 0.25 EU/ml. In addition to other requirements
speciﬁed in these guidelines, highly puriﬁed water must
contain less than 10 CFU/100 ml  and less than 0.03 EU/ml.
Highly puriﬁed water is recommended for producing
ultrapure dialysate. The dialysate’s degree of purity
will be that of the worst of its components. Ultrapure
dialysate is recommended for all types of haemodialysis.
In 2015 in Spain, 80–90% of haemodialysis was carried out
with high-ﬂux disposable dialysers. Ultrapure dialysate
is also necessary for high-ﬂux HD and in haemodiaﬁl-
tration and haemoﬁltration with on-line production of
substitution ﬂuid.
Financial constraints affecting the ability to produce
dialysate free of bacterial or ET contamination are the
reason behind many  guidelines continuing to allow two
levels of quality. Optimally, dialysate should be of phar-
maceutical quality, similar to that of parenteral solutions.
We know that stimulation of monocytes can be observed
with plasma ET levels as low as 0.05 ng/ml.38 We have to
bear in mind that the stimulation occurs with cumulative
exposure during the HD session and is also enhanced
by other adjuvant stimuli, such as complement, acti-
vated by the dialyser membrane, or the acetate in the
dialysate. That is why we have chosen ET levels for ultra-
pure dialysate similar to those for sterile ﬂuids, thereby
ensuring that there are insufﬁcient levels of ET to stim-
ulate monocytes. Bacterial contamination is the source
of ET and other substances with pyrogenic properties
and should therefore be as low as possible. The limit for
puriﬁed water of 100 CFU/ml, as indicated by most stan-
dards for use, including the European Pharmacopoeia,
may  not be low enough. To obtain dialysate with low
bacterial contamination, levels of contamination in its
three components must be low. We  also have to take
into account the fact that dialysate is a better medium
than water for bacterial growth and so the exponential
growth rate of bacteria is higher in dialysate than in puri-
ﬁed water. Despite these difﬁculties, we recommend that
the microbiological quality of water for producing ultra-
pure dialysate shall be that of highly puriﬁed (ultrapure)
water.39,40
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10.2.  Design  of  a  water  treatment  system
Nowadays, the key component of a haemodialysis water
treatment system is reverse osmosis (RO).
In technical terms, the design consists of the optimal
conﬁguration of the various components of the water
treatment system as regards size, position and purity to
ensure the quality of the treated water. The combina-
tion of a water pre-treatment system (softener, activated
charcoal and microﬁlters), reverse osmosis modules, and
a system of direct piping, with no storage tanks if possi-
ble, is the minimum conﬁguration required to produce
puriﬁed water and prevent microbiological contamina-
tion.
To produce highly puriﬁed (ultrapure) water, a system is
required based on having a second reverse osmosis mod-
ule and/or an electrochemical deioniser placed in series.
A system such as this allows the production of highly
puriﬁed water according to very demanding purity crite-
ria.
To prevent bacterial contamination and bioﬁlm forma-
tion, the water distribution system must be designed
meticulously. Acceptable materials for the piping sys-
tem are stainless steel and polyethylene. Major effort
should be directed at achieving adequate conﬁguration
of the distribution loop, with straight pipes, favouring
continuous ﬂow at high speed and preventing water
stagnation by avoiding dead spaces.1,2 Inclusion of heat
disinfection in the water treatment system, with auto-
matic programming, preferably synchronised with that
of the machines, secondary loops and an ultraﬁlter for
endotoxins are essential for obtaining highly puriﬁed
water.3
Distillation is a water puriﬁcation system based on the
change in state from liquid to gas by heating, then
condensing by cooling to return to its original liquid
state. It is effective in removing all kinds of contaminant
materials except volatile contaminants. Despite its great
effectiveness, it is not commonly used in haemodialysis
as it is expensive and cumbersome.1,2
See Appendix 2 for further information.
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10.3.  Concentrates  for  dialysis
The concentrate can be where bacterial contamination
of dialysate starts, especially if bicarbonate is used in
liquid form, as it is an excellent medium for bacterial
growth. Moreover, the salts used in the preparation of
the concentrate can lead to heavy metal poisoning.1
The Spanish Royal Pharmacopoeia and the European
Pharmacopoeia2 set out the characteristics that concen-
trates or solutions for haemodialysis must comply with.
Final concentrations of Na are allowed a margin of ±2.5%,
variability unlikely to be accepted in clinical practice. For
Na, a variation of 2.5% represents ±3.5 mmol/l, and so for
a concentration of 140 mmol/l, means a range from 136.5
to 143.5 mmol/l. Haemodialysis with these two extreme
concentrations is entirely different.3 Although through
the control of conductivity, the machines can partially
correct these errors, it also has its variability. The margins
of variability for K, Cl, Mg and Ca are ±5%, but in these
cases there is less clinical signiﬁcance. The same stan-
dard establishes the allowable endotoxin concentration
as less than 0.5 EU/ml in the diluted solution, but does
not specify the method of determination. As a method
of detecting pyrogens, it proposes inoculation into rab-
bits. In this guideline, the level of microbiological quality
has been set at the level required for puriﬁed water. The
margin of variability has been set at ±2.5% for Na in
accordance with ISO 13958:2009, and how to determine
the ET shall be determined by LAL test, as it is better
standardised.
The quality of concentrates is based on the degree
of purity of its components, both water and solutes.
Keshaviah et al.4 suggest that limits for contamination
levels, essentially of trace metals, should at the most be
of a magnitude that, once diluted to make the dialysate,
do not exceed the levels speciﬁed for puriﬁed water,
Section 4.1.2. The European Pharmacopoeia 3rd Edition
determines that the aluminium content in sodium chlo-
ride used for haemodialysis concentrates shall be less
than 0.2 ppm.
Citrate dialysate is a new alternative to using acetate
as acidifying agent. Citrate is a calcium-chelating agent
that is also used for its anticoagulant effect as it reduces
calcium ion concentrations.5 A number of long-term
beneﬁcial effects have been described in relation to cit-
rate, including reduced thrombogenicity, improvement
in clearance, inﬂammation, nutrition and tolerance,
and improved control of acid-base balance leading to
less pre-dialysis acidosis.5–13 More scientiﬁc evidence is
required to justify switching from acetate to citrate in all
haemodialysis.
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10.4.  Dialysate
Many  technical aspects of haemodialysis machines have
improved but it is still not possible to guarantee the steril-
ity of the hydraulic circuit during operation. The dialysis
bath barrels on the early machines were a point of bac-
terial contamination, as were the recirculation systems,
the canisters. The closed loop ultraﬁltration control sys-
tems also presented problems for disinfection. Today’s
machines represent a distinct advantage over the earlier
models as far as disinfection is concerned. The use of
bicarbonate as an alkalising agent has been a real prob-
lem in terms of the risk of bacterial contamination. None
of the bicarbonate proportioning systems is sterile and
contamination risk is very high. The risk of bacterial con-
tamination of acid concentrates is minimal compared to
bicarbonate.
Routine use of highly puriﬁed water to supply the HD
machines is not enough to guarantee the microbiological
purity of the dialysate. The bicarbonate in dialysate is an
excellent culture medium for bacterial growth and can be
the source of bacteraemia and pyrogenic reactions. The
machine contributes to dialysate contamination because
of the complexity of its hydraulic circuit. Both the design
of the circuit and other factors such as inadequate dis-
infection encourage the growth of bacteria and bioﬁlm
formation in the circuit. Microbial contamination of the
dialysate or the presence of by-products from the bac-
teria are potential causes of disease in HD patients
and must be prevented through the use of highly puri-
ﬁed water. As speciﬁed in Section 7, the quality of the
dialysate shall therefore be tested regularly, verifying
that the quality speciﬁcations in Section 6 are being met.
Microbiology
Microorganisms exist that are perfectly acclimatised to
hostile environments, for instance, where there are virtu-
ally no nutrients, such as treated water circuits. They are
special microorganisms and have to be treated as such.
Dialysate bacteriological quality depends largely on the
design of the water treatment plant and its distribution
system, the quality of dialysis concentrates and disinfec-
tion of the circuit and machines. It also depends on the
testing methods we use. We  are referring in particular to
the culture methods for water and dialysate samples.
Endotoxins
With a closed system, microorganisms cannot pass from
the dialysate into the blood, but ET and other pyro-
genic substances (PS) can. PS are products excreted by
the bacteria or by-products released upon bacterial cell
lysis. Some of these substances have molecular weights
of less than 10 kD and can therefore cross the dialysis
membranes by diffusion. The best known endotoxins
are lipopolysaccharides (LPS), components of the outer
membrane of gram-negative microorganisms, the major-
ity of which can be detected by the LAL test. There are
also other bacterial toxins (PS), such as exotoxins, pepti-
doglycans and muramyl peptides. A shared characteristic
of these substances is their ability to act as pyrogens. Of
all these contaminants, ET are the ones with the greatest
pyrogenic potential.
n e f r o l o g i a. 2 0 1 6;3  6(3):e1–e52 e25
The determination of bacterial ET is done with the limu-
lus test (LAL), and may be performed using: gelation,
perhaps the most common, based on the ability of these
substances to form gels; turbidimetry, based on the abil-
ity of the endotoxins to react with endogenous substrates
which are cleaved to generate turbidity; and colorime-
try, a modiﬁcation of turbidimetry based on the ability
of endotoxins to react with chromogenic substances. In
addition to the above quantitative methods, there are
other methods for detecting ET contamination based
on their immunogenic activity, such as the production
of cytokines (CK) by monocytes or neutrophils, isotopic
labelling and determination of anti-ET antibodies. As we
have said, the method most commonly used is the LAL
test. For testing the puriﬁed water, a simple technique
such as Gel-Clot shall sufﬁce. However, if it needs to be
sufﬁciently sensitive, i.e. 0.01 EU/ml, kinetic chromogenic
tests shall be required.1
Factors such as the composition or the degree of tur-
bidity of the vehicle for the sample can interfere with
ET determination, so different standard samples should
be sent to the laboratory to serve as reference. Also, ET
easily adhere to certain plastics, so glass or low-afﬁnity
plastic tubes for proteins (Mini-Sorp tubes) should be
used.
The ET detectable by LAL only account for a part of
the total potential PS and they are also the ones with
the highest molecular weight. The most useful method
for determining PS in haemodialysis is to measure
the impact on patients through cytokine production by
monocytes, but this method is both laborious and expen-
sive. A simpler method has been proposed.2 PS pass into
the blood in the dialyser mainly by back-ﬁltration, but
those with low molecular weight can also pass by back-
diffusion. Passing into blood has been demonstrated with
all dialysis membranes and it does not only depend
on the quantity of PS, but also on their quality. Pyro-
genic reactions are more  common with high-ﬂux than
low-ﬂux membranes.3 PS are able to cross the high-
ﬂux membranes more  easily and back-ﬁltration is also
more common with these. In testing for ET, it is not
only the method that is important, but also the time
the samples are taken and how they are stored. Once
the PS are in the blood, induction of monocytes is not
linear. Other factors come into play which can increase
or decrease the production of CK.4 The process is multi-
factorial and is inﬂuenced by the quantity and type of
toxin, the type of membrane, plasma factors and the
concomitant action of other monocyte activation and
inactivation systems.5 It is known that the presence of
proteins, or whole blood, is a potentiating factor. At least
two proteins are known to be necessary in this process:
lipopolysaccharide-binding protein (LBP), a transporter
protein; and bactericidal/permeability-increasing (BPI).6
Certain counter-regulatory CKs, such as IL-10, also play
a part,7 as do nutritional and immune system status. For
monocytes to produce CK, the simultaneous presence of
other stimuli or signals, such as complement activation
by the dialyser membrane or acetate in the dialysate, is
very important.
This all explains why there is generally such poor corre-
lation between colony-forming units (CFU/ml), ET levels
detectable by LAL and CK production. Destroying bacteria
decreases their concentration in the ﬂuid, but may lead to
an increase in ET concentrations, and the ET are capable
of inducing the CK production if they pass through the
dialysis membrane and are joined by other concomitant
monocyte-activating factors. Some ET at plasma levels
as low as 0.05 ng/ml are able to induce the formation of
IL-1.8
Prolonged activation of CK results in a series of alter-
ations to the immune response, causing a state of chronic
inﬂammation.9–15 Pyrogenic reactions occur in 1–5% of
haemodialysis sessions. They occur more  frequently
with high-ﬂux membranes and decrease if the dialysate
is ﬁltered through a membrane with adsorbent capac-
ity, such as polysulfone or polyamide.16–18 Polysulfone,
polyamide or posidyne ultraﬁlters are effective for ﬁl-
tering the dialysate and deliver a ﬂuid with negligible
levels of endotoxins and bacteria. This means less CK
production.16,19,20 These ﬁlters achieve their effect not
only due to their cut-off, which is 60 kD and therefore
higher than the molecular weight (MW) of many  PS, but
also by adsorption. It is therefore important that they be
regularly replaced.
A proportion of the endotoxaemia that occurs in
haemodialysis patients and some of their inﬂammatory,
vascular and nutritional complications are related to
exposure to endotoxins and other pyrogenic substances
in dialysate.20
Dialysate is produced in the dialysis machine; the age
of the machine, regardless of how well-maintained, is
related to the safety and efﬁciency of that process. We
recommend that haemodialysis machines shall have a
useful life not exceeding seven years or 30,000 hours of
operation.21,22
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10.5.  Quality  control
The frequency of monitoring of the water treatment
system is based on two levels, for both technical and
analytical monitoring: the ﬁrst level, during the vali-
dation of a new treatment plant, refurbishment of an
old facility or after a contamination requiring corrective
action; the second level, during maintenance, day-to-
day management of the treatment system, after the end
of the validation period. The tests to be performed can
be classiﬁed into three areas: technical; chemical; and
microbiological.1–4
Technical checks on the production of puriﬁed water
include:
Check that the feed water to be treated meets water for
human consumption quality criteria.5–7 It is essential
to have information on the contaminants and changes
occurring in the feed water, and any changes must be
detected at an early stage to prevent collapse of the water
treatment system and massive poisoning. A signiﬁcant
proportion of incidents related to water for haemodial-
ysis, or to the operation of the treatment system, stem
from the quality of the feed water.8–12
The proper performance of the water softener and
dechlorinator and status of the programmers that oper-
ate the running-regeneration and/or backwash system
shall be checked daily; we recommend before starting
the daily sessions, but it is also useful at the end of
the operating cycle, before regeneration, and even com-
bining the two, primarily in the validation phase. The
hardness of the water leaving the water softener shall be
tested. Disposable titration kits may be used of <1 mg/dl
sensitivity; either a permanent measuring system using
an automatic probe equipped with an alarm or colori-
metric methods. The water softener regeneration system
depends on the amount of resin and brine and the pro-
gramming of the control valve. For dechlorination, total,
combined and free chlorine shall be tested using dispos-
able kits, reagents or by installing a chlorine meter in the
circuit post activated charcoal ﬁlter(s), in order to monitor
chloramine levels and their removal.13–15
The proper operation of the reverse osmosis and/or
electro-deionization system shall be checked daily by
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measuring the conductivity of the permeate, the percent-
age of reject water and working pressures.16–19
Regular monitoring of SDI (primarily in the water pre
reverse osmosis system, but also in the feed water or
throughout the pretreatment) provides information on
the quality of the water the RO equipment is having to
work with and is particularly important when the life of
the membranes is considerably shorter than expected
and/or when the desired water quality is not being
achieved. The conditions of the water to be treated can
vary substantially over time; increases or changes in sol-
vents (especially the colloidal type) may be such that they
end up not being retained in adequate proportions by
pretreatment. Having this information helps determine
possible actions to be undertaken to optimise the work-
ing conditions of the RO membranes: modiﬁcations or
corrective actions in the water pretreatment; requesting
information on the feed water quality and the conditions
of hydraulic systems prior to the water treatment system,
etc. The SDI pre RO shall be at least < 5 and the lower it is,
the better the performance and longer the life of the RO
membranes.20–22 The reference value for the required SDI
can be found in the technical sheets provided by the dif-
ferent manufacturers of RO membranes and in any of the
manuals on water treatments for haemodialysis units.
The regularity with which the SDI is measured shall be
determined by the actual conditions and the variables
described. There will even be units where it is not neces-
sary to determine the SDI regularly because of the good
quality of the raw water.
The details for chemical monitoring are discussed in
Appendix 5. This should always be approached with the
premise of avoiding chronic poisoning.
In terms of microbiological contamination, the ﬁrst pri-
ority is to prevent the dialysate from being a source of
bacteraemia and pyrogenic reactions.23–25 The second,
more  difﬁcult to achieve, is to prevent ET and other pyro-
genic substances passing to patients, and this means
regular monitoring. When repeated positive cultures over
50 CFU/ml are observed and are resistant to disinfec-
tion, bioﬁlm and dead spaces in the piping have to be
suspected.26,27 Weekly monitoring for the ﬁrst month
during the validation phase is mandatory. During the
maintenance phase, monitoring shall be done at least
monthly. Microbiological monitoring is an integral part of
this guarantee process. There shall be protocols for docu-
menting the degree of contamination of the water along
the entire length of the chain. There shall be sample col-
lection devices placed at key points to provide adequate
levels of monitoring. Water samples shall be cultured
regularly as speciﬁed in the section on microbiological
monitoring, looking for the highest sensitivity.28,29 We
recommend R2A culture medium and, in certain cases,
TGEA in these guidelines.30
The frequency and methods used for microbiological
analysis shall be tailored to the degree of contami-
nation of the plant in particular and the frequency
of disinfection of the system. The methods used for
microbiological monitoring are described in Appendix
3. The most sensitive method shall be used, although
adjusted to the degree of contamination. Microbiologi-
cal monitoring shall be done with particular emphasis
on critical parts of the chain, the most important being
the end of the treated water distribution loop.
Endotoxin levels shall be monitored at least monthly. We
recommend that the LAL test shall be used, ensuring that
it has sufﬁcient sensitivity for the measurement to be
made.31,32
Documentation in graph form and storage of all physical,
microbiological and chemical tests is critical throughout
the monitoring process, so that data can be used as an
assessment tool over time and as accreditation of achiev-
ing and maintaining the quality of both the components
of the process and the products obtained.
Lastly, it is important to remember that both haemodial-
ysis machines and water treatment systems come under
the rules governing medical devices.33
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10.6.  Methods  for  correction  and  prevention
Although no general rules can be laid down, it is a fact
that frequent disinfection of the water treatment sys-
tem is critical for preventing contamination. When a new
treatment system is put into operation, it shall be dis-
infected weekly in order to adequately clean the resins
and the piping system. The frequency of disinfection
shall then be adapted to the conﬁguration of the sys-
tem in question and the results of the microbiological
tests. The optimal interval between disinfections shall
be established based on the kinetics of recontamination
after each disinfection process. The only way to prevent
bioﬁlm formation is the advance use of the appropriate
disinfection method. The frequency, type of disinfec-
tion, concentration and exposure time to the agent shall
depend on the type of material used in the circuit and
shall conform to the manufacturer’s recommendations.
We  recommend full disinfection of the entire system at
least once a year.
Standard operating procedures shall be in place for regu-
lar disinfection of the water treatment system to prevent
the formation of bioﬁlm. The maintenance of the water
treatment plant shall include a series of measures involv-
ing frequent disinfection cycles, whether chemical, heat
or mixed, of the entire chain, ﬁlter and exchange resins,
which shall depend on the degree of contamination, and
destruction of bioﬁlm in the circuit. Periodic replace-
ment of the various system components, such as resins,
water softener and electro-deionization system, acti-
vated charcoal and ﬁlters shall be carried out according to
the microbiological results and the expiration date. This
avoids spread from highly contaminated resins.1
One major problem is the formation of a bacterial bioﬁlm
in the circuits. This is generally associated with repeated
counts of more  than 50 CFU/ml in water or dialysate. In
order to destroy bioﬁlm, it is essential to use both disin-
fectants and detergents at sufﬁcient concentrations and
with sufﬁcient exposure time.2,3 In some instances, it
may be necessary to inspect the installation and even
change components.
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HD machines shall be disinfected after the end of each
session, whether by heat or use of chemical agents.
Proper maintenance of the machines involves regular
cleaning of the hydraulic circuit with a detergent that
removes organic residue, descaling with an acid solu-
tion to remove calcium and phosphate precipitates and
chemical and/or heat disinfection. In all cases, cleaning,
descaling and disinfection shall conform to the manufac-
turer’s recommendations. The circuit should be replaced
if found to be highly contaminated or bioﬁlm is detected.
Cleaning of the water treatment system, distribution and
haemodialysis machines shall generally be performed in
line with the speciﬁcations of each manufacturer, which
shall be according to the corrosion resistance of the
materials used. There may be occasions when, despite
following these speciﬁcations, we  ﬁnd bacterial contam-
ination resistant to the treatment. Should this occur, we
have to change product; ﬁrst determining its properties
and mode of action. The cleaning has to achieve three
goals: (1) bacterial, including spores, fungal and viral
disinfection; (2) descaling; and (3) cleaning or removing
deposits of proteins, lipids and other organic products
by detergent action. The three actions are interlaced. An
example is the treatment of a bacterial bioﬁlm, where
cleaning and descaling is more  important than the bac-
tericidal action. Each of the main chemicals used in the
cleaning process has a predominant action: hypochlo-
rite is, in sufﬁcient concentrations, a good bactericide
and cleaner for organic deposits; peracetic acid is essen-
tially bactericidal and has some descaling properties;
acetic acid descales and is moderately bactericidal; and
citric acid is the best agent for descaling. This means
that achieving the three goals requires the use of more
than one product, such as the classic combination of
hypochlorite and acetic acid. When there is evidence of
signiﬁcant deposits of calcium and magnesium carbon-
ate in the circuits of the machines, citric acid is required.
With the methods of disinfection, the contact or expo-
sure time required for bactericidal action has to be taken
into account. This can vary greatly according to the
disinfectant and the microorganism to be treated and
depending on the concentration achieved and the tem-
perature; 4% formaldehyde at 20 ◦C requires 24 hours to
achieve good disinfection, while 1% peracetic acid at
20 ◦C needs 11 hours and 0.75% glutaraldehyde only 1
hour. Another aspect is the ability of these substances
to cause corrosion; sodium hypochlorite (bleach), which
is a good detergent due to its oxidising properties, is
able to modify the properties of certain membranes such
as polysulfone, increasing removal of proteins 10-fold.4
Among the different disinfectant substances, incompati-
bilities exist, and they cannot therefore be used together;
if necessary, they should be used sequentially, after suit-
able rinsing. Acetic, citric and peracetic acids should not
be mixed with hypochlorite or hydrogen peroxide or with
any of the bases in general. Aldehydes cannot be mixed
with acids, ammonia or phenol. In general, all these
substances are toxic and shall be handled with suitable
precautions. The majority can trigger allergic reactions.
There are a number of disinfectant mixtures available
on the market speciﬁcally designed for haemodialysis:
Instrunet HD® (1.15% sodium chlorite and 0.06% peroxy-
acetic acid); Dialox® (hydrogen peroxide, acetic acid and
peroxyacetic acid) and Actril® (0.8% hydrogen peroxide
and 0.06% peroxyacetic acid)5; Puristeril 340® (hydrogen
peroxide and peroxyacetic acid); Cold Sterilant® (20–24%
hydrogen peroxide, 4–6% peracetic acid and 8–10% acetic
acid).
The methodology for the disinfection of the water
treatment system shall cover the following aspects: dis-
infection shall be done periodically, before a high level
of contamination is detected; the product or products
used shall be selected according to the recommendations
mentioned above and those speciﬁed by the manufac-
turer. The scheme mentioned below is designed for
Dialox®, but can be used for other disinfectants chang-
ing the concentration and contact time. In this case, the
concentration to be used is 5%; 5 litres of Dialox® diluted
in 95 litres of water. This solution has to spread to and
remain in contact with all points of the system for at
least 30 minutes. The contact shall preferably be under
dynamic conditions, with the disinfectant circulating. A
stringent wash-out shall then be carried out, followed by
testing at various points, and in particular the connec-
tions to the machines, to conﬁrm that the disinfectant
has been rinsed away. Suitable detectors shall be used;
in the case in question, potassium iodide starch paper,
which detects up to 40 ppm or enzymatic strips that
detect up to 7 ppm. Before disinfection it shall be con-
ﬁrmed that all the system components are compatible
with the disinfectant.
Regular microbiological monitoring is essential to opti-
mise disinfection and check its effectiveness.
In order for the dialysate and haemodialysis machines to
meet basic safety standards, according to the machine
type and technical speciﬁcations, there shall be a
standard operating procedure with the step-by-step
instructions to be followed before the start of each ses-
sion. The user shall check that:
– The latest test results for the water and concentrates
are within acceptable ranges.
– The machine has been completely disinfected.
– All the disinfectant used has been completely rinsed
out; under no circumstances shall this step be left
out.6,7
Ultraﬁltration of the dialysate through an appropriate
ultraﬁlter at low pressure is the method being used to
obtain ultrapure dialysate. Most of these ﬁlters have syn-
thetic membranes with a cut-off or molecular exclusion
of about 40 kD and high adsorptive capacity. Polysulfone
and polyamide are the most commonly-used mem-
branes in these ﬁlters. They are now being used to ﬁlter
the dialysate just before the dialyser.8–10 They remove
all kinds of particles, bacteria and endotoxins, many  of
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them from the circuits of the haemodialysis machine.
This prevents passing into the patient through the dial-
yser. Both online haemoﬁltration and haemodiaﬁltration
require speciﬁc machines that include “cold sterilisation”
of dialysate by two or more  ultraﬁlters. To date, ultraﬁltra-
tion of dialysate is the only method to have been proven
effective in clinical practice. These ultraﬁlters have the
following characteristics:
1. Basically hollow-ﬁbre ﬁlters composed of synthetic
membranes (polysulfone, polyamide, posidyne)
2. They have to be placed in series in the dialysate line
3. They purify the dialysate by ﬁltration (based on size
exclusion and wall structure) and adsorption mecha-
nisms (due to hydrophobic interactions)
4. They have to produce a high-quality “ultrapure”
dialysate
5. They must guarantee microbiological quality equiva-
lent to that required for parenteral solutions (infusion
or haemoﬁltration solution)
6. Their air tightness has to be monitored and they need
to be disinfected periodically
7. Sterilised ultraﬁlter with retention capacity of11):
• Bacteria: Log value > 7 Pseudomonas diminuta
• Endotoxins: Log value > 3–4 E. coli and P. aeruginosa
With regard to centralised concentrate systems, we  do
not recommend bicarbonate concentrates in this guide-
line; and acid concentrates rarely become contaminated.
We recommend that periodic descaling, washing and
inspection shall be carried out.12
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10.7.  Rationale  for  using  an  ultrapure  dialysate  in
haemodialysis  today
The ANSI/AAMI1 guidelines recommended that pure
ﬂuid for haemodialysis should have no more than 200
colony forming units (CFU)/ml and 2 endotoxin units
(EU)/ml, and that for ultrapure ﬂuid, there should be
no more  than 0.1 CFU/ml and 0.03 EU/ml. Meanwhile,
the European Renal Best Practice (ERBP)2 published in
2002 recommended <100 CFU/ml and <0.250 EU/ml for
pure ﬂuid and <0.1 CFU/ml and 0.03 EU/ml for ultrapure
ﬂuid. The differences were uniﬁed by the International
Organization for Standardization with ISO 11663 in 2009
and ISO 23500 in 2011,3 which recommended pure ﬂuid
with <100 CFU/ml and <0.5 EU/ml, and ultrapure with
<0.1 CFU/ml and <0.03 EU/ml. According to all these
guidelines, substitution ﬂuid used for HD should have
<10−6 CFU/ml and <0.03 EU/ml.
The Japanese Society of Nephrology4 establishes as
microbiological standards in pure ﬂuid <100 CFU/ml and
<0.05 EU/ml measured at least once a month, and in all
machines at least once a year. The standards for ultra-
pure ﬂuid are <0.1 CFU/ml and <0.001 EU/ml. The level
for alert should be 50% of the maximum allowable limit
in any of the cases, except for endotoxins in ultrapure
ﬂuid. The Japanese society recommends <10−6 CFU/ml
and <0.001 EU/ml for substitution ﬂuid.
Ultrapure dialysate is absolutely necessary when
used as substitution ﬂuid for on-line haemoﬁltration
or haemodiaﬁltration. To minimise inﬂammation in
patients on haemodialysis, all dialysis units shall strive
to achieve ultrapure dialysate for all types of haemodial-
ysis. The routine use of ultrapure dialysate requires
the ﬁtting of speciﬁc ultraﬁlters in the dialysate circuit.
(Level of Evidence B, 1)
The standards vary and some recommendations suggest
reducing to 0.1 CFU/ml, using sensitive microbiologi-
cal methods, and <0.03 EU/ml to deﬁne an ultrapure
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dialysate.5 The ultrapure ﬂuid is achieved using three
basic principles: ultrapure water; sterile ultraﬁlters inter-
posed in the path of the ﬂuid in well-designed HD
machines; and strict compliance with disinfection pro-
cedures and microbiological monitoring.
According to all the recommendations, the current use of
dialysers with high-ﬂux membranes specially designed
to allow convective transport is imposing the generalised
use of ultrapure dialysate.6,7
The use of ultrapure dialysate has been accompanied
by an improvement in the inﬂammatory state of the
patient.8 The improvement of this state reduces the
need for erythropoietic factors,9 reduces levels of B2
microglobulin10 and improves the lipid and myeloper-
oxidase proﬁles.11,12 Monocyte activation and apoptosis
improve when using ultrapure dialysate.13 Its use also
improves preservation of residual renal function14 and
nutritional status.15 Ultrapure dialysate is associated
with a decrease in vascular endotoxins, with the result-
ing improvement in vascular elasticity and systemic
inﬂammation.16
A recent meta-analysis shows that the use of ultrapure
dialysate in haemodialysis patients causes inﬂamma-
tory and oxidative stress markers to fall, increases
serum albumin and haemoglobin and reduces erythro-
poietin requirements.17 It also concludes that although
those results are subrogate markers, it would be
assumed that it must have cardiovascular beneﬁts.
Another study found increased survival in patients
treated with high-ﬂux dialysis when ultrapure dialysate
is used, when compared with a conventional or pure
ﬂuid.18
Using ultrapure dialysate shall be mandatory in patients
who  are being dialysed with high-ﬂux membranes, and
in those with more  convective transport such as online
haemodiaﬁltration. The reason for this is the evidence
that the use of ultrapure dialysate in these patients
improves survival and cardiovascular events.19–21 In
Spain, where 80–90% of patients are dialysed with high-
ﬂux membranes, it is mandatory that all machines have
ultraﬁlters and that patients have the beneﬁt of ultrapure
dialysate.
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10.8.  Highly  puriﬁed  water,  conductivity  and  total
dissolved  solids  (TDS)1–9
In other areas unrelated to dialysis, ultrapure water is
considered to be water whose conductivity does not
exceed 0.5 S cm−1, since it is very important that water
cannot act as an electrical conductor, without specifying
its intended use (photo labs, electronics manufacturing,
etc.). By using the same term for haemodialysis water
and setting the conductivity limit 5 S cm−1, there are a
number of considerations which have to be taken into
account.
The conductivity limit required in dialysis is to ensure
that the concentration of chemical contaminants in the
dialysate, valued together, does not exceed levels con-
sidered toxic to patients. It is not therefore a problem of
water acting as an electrical conductor. Total dissolved
salts, solutes or solids (TDS), in mg/l, and conductiv-
ity are related as follows: the TDS are equivalent to the
conductivity of water, in micro Siemens, multiplied by
a factor ranging from 0.54 to 0.96 depending on the
solute, although generally it is a value chosen somewhere
between the two. According to this conversion, 2 mg/l
of a substance, or the sum of several substances dis-
solved in water, would have a conductivity of between
2.08 and 3.7 S. If instead of 2 mg/l the TDS value was
4 mg/l, although the concentrations of solutes are within
the set range, the conductivity could be outside the range
considered suitable for puriﬁed and ultrapure water for
haemodialysis.
If we compare this with the maximum values of the
chemical components that may be present in the water
for haemodialysis, whether ultrapure or not, colliding see
that certain elements can be in amounts up to 50 mg/l
(sodium) and therefore incompatible with the indicated
conductivity. Thus, if we  had water with microbiologi-
cal, endotoxin and chemical levels well within the limits
required for ultrapure water listed in the guide, but the
conductivity was outside the ranges indicated, would it
be correct to say that the water does not meet the rec-
ommended requirements for use in haemodialysis and
ultrapure water?
Depending on the hardness of the feed water, pre-
treated water can contain a high concentration of
sodium chloride from the water softeners. This can be
counteracted using reverse osmosis in series and an
electro-deionization system, which would give us levels
of conductivity below 0.5 S. This type of conﬁguration
is not usually used in haemodialysis water treatment
systems, although it may be advisable in places with very
hard feed water and/or where it is necessary to lower the
conductivity.
It is also important to remember that gases dissolved in
the water interfere with the measurement of conductiv-
ity, one of these being CO2, which can come naturally
from the water itself or sometimes be added to obtain
optimum pH. Other elements may also be added to cor-
rect the pH and affect the ﬁnal conductivity.
Given the above data and arguments, it is acceptable that
both puriﬁed and ultrapure water may have a higher con-
ductivity than the recommended, provided the levels of
chemical, microbiological and endotoxin elements are
within the indicated range.
Nevertheless, it is important to stress that the conduc-
tivity achieved under optimal operating conditions, with
all physical and chemical parameters being met, must
be maintained over time, and that any changes, if they
exceed a pre-set limit, have to be diagnosed and corrected
if necessary. Monitoring conductivity allows on-the-spot
control of the operation of the reverse osmosis equip-
ment.
The Silt Density Index (SDI) shall be less than 5 in the feed
water to the reverse osmosis equipment; some technical
manuals for osmosis membranes or equipment recom-
mend that it should be less than 3. When premature
saturation of osmosis membranes occurs (loss of pro-
duction ﬂow rate and/or pressure variations), knowing
the SDI and how it varies over time gives an indication of
the suitability of the water quality. Measurement of SDI
is regulated by ASTM International (formerly American
Society for Testing and Materials).
This guideline requires a conductivity level and monitor-
ing thereof because it is the method available in all water
treatment systems and is the best method for warning us
of malfunction.
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• Poorly controlled chlorination, whether too much or
too little, which can cause hazardous variations in
water for haemodialysis.
This does not necessarily mean that it is the haemodial-
ysis units that should be responsible for complying with
the above RDs, but it shall be their responsibility to
acquire documented veriﬁcation that the actions and
controls speciﬁed in the RDs have been carried out.
In hospitals, this job is generally the responsibility of the
Preventive Medicine and/or Maintenance departments.
In external haemodialysis units, and even in small hos-
pitals, there may be two contending factors:
1. That due to the volume stored and/or consumed,
they are considered as potable water “managers” and
therefore have to comply with the RDs.
2. That for the same reasons, they are not considered
to be “managers”, so their role is limited to acquiring
the documentation from the potable water supplier
or local authorities, depending on which has ultimate
responsibility for implementation of and compliance
with the RDs.
When the supply of feed water to a haemodialysis water
treatment plant does not directly come under a health
authority but an intermediary, for example a neighbour-
hood association, tanker lorry, hospital storage tank, etc.,
guarantee of compliance with the above regulations shall
be the responsibility of the people in charge of those bod-
ies.
Premises where the equipment and ancillary facilities,
such as air extraction and supply, drainage, electrical
installations, etc. are located shall comply with the spe-
ciﬁc rules and monitoring for such components, with
particularly close monitoring for elements whose inﬂu-
ence may alter proper functioning or the results of the
analyses performed (e.g. electrical protection, air vents
above sampling points, etc.).
The decrees can be downloaded from:
https://www.boe.es/boe/dias/2003/02/21/pdfs/A07228-
07245.pdf
http://www.boe.es/boe/dias/2003/07/18/pdfs/A28055-
28069.pdf
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A.2.1.  Components  of  the  water  puriﬁcation  systemsde agua de consumo humanoBOE núm. 172. http://www.
boe.es/boe/dias/2009/07/17/pdfs/BOE-A-2009-11876.pdf.
onﬂicts  of  interest
he authors have no conﬂicts of interest to declare.
cknowledgements
e  would like to thank Prof. Carlos Quereda Rodríguez-
avarro for his invaluable contribution to the methodology
n this guideline.
Appendix  1.  A.1.  Characteristics  of  the  feed
water
The quality of the feed water to the haemodialysis unit
is fundamental in terms of the design of the water treat-
ment system and the results obtained. Feed water is
synonymous with raw water, water to be treated and sup-
ply water. The quality of this water shall comply with
Royal Decree (RD) 140/2003 on the quality criteria of water
for human consumption and RD 865/2003, which estab-
lishes the health and hygiene criteria for the prevention
and control of Legionnaires’ disease.
Apart from the obvious health and hygiene and quality
criteria for potable water, both decrees set out actions for
maintenance and upkeep in hydraulic systems.
This becomes of paramount importance in haemodial-
ysis units located in hospitals, since these centres are
generally considered “water managers” due to the vol-
ume  of consumption and storage of potable water.
Mismanagement or non-compliance with these RDs lead
to a wide range of problems in the treatment of water for
haemodialysis. The following are some common exam-
ples:
• Poor maintenance of the cisterns, which can lead
to unwanted increases in all types of elements in
the water which then cause serious defects in the
haemodialysis water treatment system. The cisterns act
as ﬁlters by decantation; excessive accumulation of silt deriv-
ing from decantation can under certain circumstances cause
the silt to be drawn into the hydraulic distribution network,
with the consequent problems.
Water treatment systems can be divided into 3 sections:
– Pre-treatment: feed or raw water tanks; chemical
injection systems; ﬁlters; water softener; activated
charcoal; microﬁlters.
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– Treatment: One or more  reverse osmosis systems and,
optionally, an electro-deionising system.
– Post-treatment: UV lamps; ultraﬁlters; if applicable,
treated water tank; and distribution system.
A.2.1.1.  Pre-treatment
Feed  or  raw  water  supply
Shall be designed to guarantee a constant supply,
whether via more  than one supply connection, raw water
tanks, pumps in duplicate, etc. The importance of this
increases if the water treatment system is online, i.e. the
product or treated water is delivered directly to the dis-
tribution network. If there are water tanks, they shall be
opaque to prevent the growth of algae, and closed, with
access for cleaning and disinfection. We recommend
installing an individual meter to measure the consump-
tion of the water treatment plant.
Chemical  injection  systems
Certain products, when added to water, can exercise dif-
ferent functions:
– Sodium bisulﬁte for removing chlorine/chloramines
– Acids for reducing the pH of the feed water and
improving the efﬁcacy of the activated charcoal
– Chlorine or ozone to control bacterial growth.
If any automated equipment for adding chemicals is
installed, there shall be a device or equipment to monitor
that parameter.
In principle, given the purpose for which we aim to obtain
the particular quality of water, we  should be thinking
about the need to remove unwanted elements without
having to introduce others that will have to be removed
later.
Pressure  regulator
Responsible for maintaining a constant pressure at the
treatment system water inlet in order to prevent pres-
sure surges that could lead to breakage of some element
in the pre-treatment system. Pressure gauges shall be
positioned at both the inlet and the outlet.
Pressure  gauges
Installed at various points along the treatment system,
they allow us to visualise pressure losses at each point,
helping us to identify potential failures or saturation of
any of the elements by comparing pressures.
Pre-ﬁltration  –  sediment  ﬁlters
Pre-ﬁltration removes items in suspension1–7 that can
cause premature clogging of the osmosis membranes or
coating of the activated charcoal particles and softener
resins. The system shall therefore be installed as the ﬁrst
element of pre-treatment and inserted at some point in
the pre-treatment circuit.
It may consist of exclusion ﬁlters (wound or screen), cal-
ibrated sand bed ﬁlters, which can be regenerated by
backwashing, or hydrocyclone ﬁlters. Even if the raw or
feed water is conﬁrmed as having minimal concentra-
tions of particles in suspension, they should always be
installed, as they cost little, including for maintenance,
and the potential beneﬁts are considerable.
In some cases, if there is a high concentration of particles
in suspension, it may be necessary to install more  than
one item in series, gradually decreasing pore size.
The sand/anthracite ﬁlters have the advantage that they
can be backwashed. The dimensions in terms of pore size
or discrimination capacity of the sand in the ﬁlters can
go as far as the exclusion of particles >5 m,  but typically
about 20 m.  To remove even smaller particles, the larger
pore-size ﬁlters will need to be followed by additional
microﬁlters in series. The choice of ﬁlters shall depend
on the characteristics of the feed water, always placing
them in order from larger to smaller pore size. The ﬁl-
ter container shall be opaque to prevent growth of algae.
The ﬁlter elements must have pressure gauges at the
inlet and outlet to detect pressure drop as an indicator
of fouling.
In the hydrocyclone ﬁlters, the ﬁltering process takes
place through the discs with the water to be ﬁltered
entering via a tangential inlet causing a spiral ﬂow, the
hydrocyclone effect, which keeps dirt particles in sus-
pension away from the ﬁlter element and drags them
helically to the bottom of the ﬁlter housing. The ﬁlter
element is a slotted disk cartridge made of polypropylene
that ensures high resistance and quality of ﬁltration; pro-
viding the ﬁlter with a long life. Filtration grades from 5
to 200 microns. Cleaning involves manually cleaning the
ﬁlter cartridge; easy disassembly of the ﬁlter cartridge
allows it to be cleaned more  thoroughly. Cleaning can be
automated by incorporating an automatic purge kit.
Water  softeners
Their job is to remove calcium and magnesium (hard-
ness of the water) by ion exchange when passed through
a resin bed.1–7 Hard water can cause precipitation of cal-
cium carbonate.
First of all, the precipitation can damage elements such
as the osmosis membranes. Secondly, if the hard water
reaches the patients through the distribution network, it
can cause so-called hard water syndrome.
The water softener contains ion exchange resins which
exchange sodium ions (Na+) for calcium (Ca++), magne-
sium (Mg++) and other polyvalent cations that make the
water hard. Once the resin is saturated with Ca and Mg,  it
is regenerated with brine. This causes the resins to newly
acquire cations of sodium Na+ and displace the Ca++ and
Mg++ from the resin.
Water softeners are usually installed in a twin conﬁgura-
tion, i.e. two resin ﬁlters controlled by one or two heads.
Twin water softener (Duplex) or two independent paral-
lel water softeners. The control valve will be automatic
and it shall have a salt storage tank.
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The operation of the ﬁlters may be:
– Alternative: One of the ﬁlters is operating and the other
regenerating or in waiting phase.
– Parallel: The two ﬁlters work in unison, but they never
regenerate simultaneously.
This is due to the fact that the regeneration process is
slow because, once saturated with Ca and Mg,  the resins
need contact time with the brine for cation exchange.
In addition, a backwash is necessary for expansion and
cleaning of the resin.
Another important aspect to consider is that the time
between regenerations is sufﬁcient; to guarantee that the
contact time between the water and the salt (in the salt
tank) is sufﬁcient to generate the brine.
The regeneration system should have a safety mecha-
nism that prevents the brine from the regeneration from
passing into the treated water.
The regeneration shall be automatic and may be pro-
grammed according to:
–  Volume of circulating water: This volume shall be pro-
grammed according to the number of litres of resin,
the resin’s exchange capacity and the hardness of the
water.
– Time:  Performing regeneration overnight. Hardness
tests should be carried out on the softened water prior
to regeneration. Filters must do a regeneration at least
once a day.
If the water is extremely hard, more  than one battery
of water softeners may be required. In such cases, it is
important to bear in mind that water softeners can pro-
duce large amounts of sodium as a result of the cation
exchange in the resins.
The salt used for regeneration shall meet the speciﬁca-
tions set out in RD 1424/83 and CE 91155 EWG,  as using
unreﬁned salt or sea salt directly can result in undesir-
able elements in the subsequent steps of the treatment
system, such as particles, iodine, etc.
Charcoal  ﬁlter
The job of the charcoal ﬁlter is essentially to retain
chlorine and/or chloramines. Chlorine can cause serious
damage to some osmosis membranes and if it reaches
the patient, can cause haemolysis.
The activated charcoal ﬁlter removes chlorine and
chloramines added to the water to prevent bacterial con-
tamination by adsorption; it can also remove organic
substances dissolved in the water.1–10 The charcoal ﬁl-
ter shall be installed post water softener to avoid leaving
the earlier steps of the treatment unprotected against
microbial contamination after removal of chlorine and
chloramines.
The size shall be determined according to the level
of chlorine in the water. They shall contain a suitable
charcoal both in terms of source and activation. We
recommend using 12 × 40 acid-washed granular acti-
vated charcoal (GAC) with a minimum iodine number of
≥900.
Whenever feasible, replaceable charcoal cartridges shall
be dispensed with in favour of backwashing charcoal ﬁl-
ters. This is because the charcoal cannot be regenerated,
so gradually becomes exhausted. This means that with
replaceable cartridges, chlorine or chloramines may be
present due to partial exhaustion and not be detected
immediately.
Backwashing means circulating the water in the opposite
direction inside the charcoal ﬁlter which makes it swell
or expand. This is important since while in operation, the
charcoal becomes compacted. Channels can form, allow-
ing the water to ﬂow through and thereby minimising
contact with the charcoal, leading to the risk that the
chlorine and/or chloramines may not be removed. This
process helps in part to preserve the charcoal from possi-
ble contamination by introducing water through part of
the internal circuit in which it always circulates without
the presence of chlorine. The backwash shall be per-
formed at least once a day. It is generally programmed to
run overnight when there is no demand for water from
the unit.
The design and size of the ﬁlters shall be suitable to
obtain a total EBCT of over 7 minutes, although we  rec-
ommend over 10 minutes.
EBCT = V
Q (minutes)
where V = volume of charcoal in litres; Q = estimated
maximum ﬂow rate through ﬁlter (l/min); recommended
EBCT at least 10 min; Example: For an RO with a maxi-
mum (feed) of 40 l/min, 400 l of charcoal should be used
(400/40 = 10 min).
As it cannot be regenerated, the charcoal shall be
changed regularly to prevent it from releasing adsorbed
substances due to saturation, micro particles of charcoal
that have been reduced by friction, etc. More  than one
ﬁlter may be used and they may be installed as follows:
A. In series2,8,10: one ﬁlter after another. This guar-
antees that the water travels at the highest speed
possible and if one of the elements fails, the other
continues working. The disadvantage of this is that,
if the ﬁrst ﬁlter removes all the chlorine, the sec-
ond ﬁlter will never have contact with chlorine and
chloramines, not even during backwashing, as the
ﬁrst ﬁlter will remove all the chlorine under normal
operating conditions, and this could lead to bacterial
contamination. It is essential that the level of chlo-
rine/chloramines can be measured independently in
both ﬁlters.
B. In parallel: the water enters both ﬁlters simultane-
ously and therefore only passes through one ﬁlter.
In this case, the water circulates more  slowly which
increases the contact time (EBCT). If one of the ele-
ments fails, it means that some of the water will
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still contain chlorine and/or chloramines. It has the
advantage that the two ﬁlters do the backwash with
chlorinated water and that if one fails, the line can be
cut off while the second line remains operational.
After the ﬁlter, there shall always be a microﬁlter, of
about 5 m,  or even better 1 m,  to guarantee that in the
event of release of charcoal particles, they cannot pass
through to subsequent parts of the treatment system
(see manufacturer’s requirements for the water treat-
ment equipment in the subsequent step).
A.2.1.2  Treatment
Reverse  osmosis
Based on the physical principle of osmosis across a
semipermeable membrane, the ﬂow of water is reversed
by pressure from a hydraulic pump.1–7,11–16 The mem-
branes are capable of retaining 90–99% of ions and
95–99% of organic elements. The yield is determined by
the product and reject streams. The product or permeate
ﬂow is the water that crosses the osmosis membrane and
is sent for use. The reject or concentrate ﬂow is the water
that does not cross the membrane as it contains high
concentrations of elements dissolved in the water that
cannot pass through, and it is sent to drain or partially
or entirely fed back to the system; for one-stage osmo-
sis systems, this generally tends to be 50–50, although it
can vary depending on the design of the equipment, the
characteristics of the raw water, the pretreatment and
the quality to be obtained with the above parameters.
Yield (%) = Permeate ﬂow
Permeateﬂow + Reject ﬂow × 100
The effectiveness of the membrane or ion rejection is
determined by the input and output conductivity (electri-
cal parameter; inverse of resistivity), i.e. the conductivity
of the water when it goes into the osmosis system and
comes out of it (permeate) ready for use or to continue on
to subsequent processing elements. The formula usually
applied to determine the efﬁcacy or ion rejection is:
Ion rejection (%)
= Input conductivity − Permeate conductivity
Input conductivity
Obviously, the more  effective, the higher the water qual-
ity, but this can be misleading because a very high input
conductivity level will be reﬂected by the permeate or
outlet also having high conductivity, even with efﬁciency
above 99%; conversely, a low input conductivity will be
reﬂected with low outlet or permeate conductivity, but
with low efﬁciency (<90%). Conductivity should be used
as the monitoring parameter for proper functioning of
the system; when we compare the results of the chemical
analyses with the usual value, it will tell us that there are
no variations in the ionic components of the water. There
are parameters that can affect the conductivity reading
but without implying any reduction in the water quality,
such as the presence of microbubbles.
In addition to conductivity, the pressure the membranes
are subjected to and the permeate and reject ﬂows
serve as indicators of the water quality once estab-
lished according to the manufacturer’s speciﬁcations.
The number of membranes used will be determined by
consumption of treated water; obviously this has to be
as ﬁnely adjusted as possible, since using the bare mini-
mum number of membranes can mean having to raise
the pressure over time (saturation of the membranes)
and even having to increase the permeate ﬂow with
respect to the concentrate (reject) ﬂow, which would lead
to a decrease in the ﬁnal quality.
Osmosis equipment has to be periodically descaled and
disinfected; this work will essentially depend on the
quality of water entering the system, but it should be
avoided as far as possible, as both operations result in a
decrease in the effectiveness of the membrane.
The correct design and subsequent monitoring of the
pre-treatment components (pre-ﬁltration, water soft-
ening and dechlorination) are essential for the proper
operation of the osmosis system, as failure of a compo-
nent or poor design can have a signiﬁcant impact on the
osmosis membranes. For example, the following aspects
are crucial: complete removal of chlorine to prevent per-
foration of the membrane; hardness removal to prevent
premature clogging of the osmosis system; prevention
of excessive presence of matter in suspension, including
elements from the pre-treatment (charcoal), as this can
cause contamination, clogging, etc. Another factor that
can inﬂuence the membranes is the water temperature;
at higher temperatures, the membrane increases water
production, but this may result in a lowering of quality;
at lower temperatures, the opposite occurs. The osmo-
sis system shall be equipped with audible and/or visual
alarm systems which signal when conductivity deviates
from the allowable limits.
Osmosis  membranes.  The quality of pre-treated water
must be taken into account when designing the reverse
osmosis system, as the operating parameters will have
to be set accordingly. Consult the manufacturer’s rec-
ommendations on the design and operation of a reverse
osmosis system for the membranes to use.
The ﬁgure below shows a basic idea of the difference
between one-stage (top) and two-stage (bottom) osmosis:
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Reverse osmosis.
Types of configuration
Two stage osmosis.
• One-stage: classic conﬁguration, may have a back feed
from the outlet to the inlet in order to improve yield
(redundant ﬂow). Water consumption is high - good
yield would be 40% reject, which is sent to drain, and
60% product; the usual is 50%. If the incoming water
has high levels of dissolved elements, a certain pro-
portion of them will pass through the membrane, as it
retains a percentage (90–99%). In the event the osmosis
fails, dialysing is not recommended.
• Two-stage1,6,11–13: The reject water from the second
stage is recovered in full and sent back to the inlet.
Lower water consumption, since the conﬁguration of
the system means it can work with up to 20% reject.
Even if incoming water inlet has high levels of dis-
solved elements, very good quality water is achieved,
as the second stage acts only on the permeate water
from the ﬁrst. This conﬁguration is recommended not
only due to the better water quality obtained, but also
because, if either of the stages fails, work can continue
with the other, producing water quality similar to a
one-stage system. Each stage shall have its own pump
system.
The equipment shall have CE marking and should be
certiﬁed as medical device (medical electrical equip-
ment = medical device).
Deionisers1–6,11,12,14–16
Usually added as an alternative to a second stage of
osmosis.
Between 1% and 10% of the ions are not retained by
osmosis (one-stage). Therefore, if there are very high con-
centrations of ions pre-osmosis, there may also be a high
presence in the output. We recommend use of deionis-
ers in places with high ionic load. There are currently two
classes of deionisers:
• Electro-deionization system1,11: mixed-bed resins
with small volume separated by membranes and sub-
jected to a polarised electric ﬁeld, which causes anions
and cations to migrate to the corresponding electric
pole through the membrane. A stream of waste water
between the other side of the membrane and the corre-
sponding electric pole causes ﬂushing of the ions that
have crossed the membrane, i.e. continuous regenera-
tion. If a deioniser is necessary, an electro-deionization
system shall be used.
Water subjected to osmosis
Reject water
Product water
• Ion exchanger1–5: Works in a similar way to the water
softener, but in this case it is a mixed bed: an anion and
a cation exchanger. They may be in one tank or two
different tanks. Exchanges Na+, K+, Mn+, etc. cations
for hydrogen ions (H+) for the cation exchange bed
and HCO3, Cl, F, SO4, etc. anions for hydroxide (OH−),
and as a result of the two processes, H2O is produced.
Ion exchangers can easily become contaminated due
to their large volume and the lack of bactericidal ele-
ments in the water; if they become saturated, they
start releasing retained ions, so have to be constantly
monitored by a conductivity meter at the outlet, must
have an alarm system and require regular epidemio-
logical testing. Due to the aggressive agents that have
to be used for regeneration (acid for the cation column
and caustic soda for the anion column), this is usu-
ally done outside the centre. For that reason, the use
of ion exchangers is not recommended, particularly in
view of the alternative of using an electro-deionization
system.
A.2.1.3  Post-treatment
Ultraﬁlter  or  submicron  ﬁlter1–3,5,11,13
Generally used in addition to one-stage reverse osmo-
sis, or both simultaneously, when storing treated water
to prevent contamination in the tanks from passing
into the distribution network. Submicron or ultraﬁlters
mainly retain bacteria and other elements dissolved in
the water; depending on the pore size, they will also
retain endotoxins. The endotoxin adsorption capacity
varies according to the type of membrane. Some of these
ﬁlters are very similar to a large dialyser, having very sim-
ilar membranes, with some of the water being directly
rejected. Breakage of these ﬁlters due to overpressure
or excessive prolongation of their useful life could allow
contaminants through to the rest of the circuit. The pore
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size selected will depend on the previous system. If ultra-
ﬁlters are placed pre osmosis, they can quickly become
clogged. If the osmosis provides water free of high con-
centrations of dissolved elements (bacteria, ions, etc.),
the ﬁlter to use would be one which acts as a barrier to
endotoxins, with a size of <1 angstrom approximately.
The integrity and saturation of the membrane shall be
guaranteed by installing gauges at the input and output
to measure changes in pressure.
To produce ultrapure dialysate, ultraﬁlters are necessary
in the dialysis machines. For “online” haemodiaﬁltration,
a second ultraﬁlter is necessary to obtain substitution
ﬂuid.
Ultraviolet  lamp
Short-wave ultraviolet light is bactericidal1–3,5,17 and this
can result in the massive presence of endotoxins; UV
lamps shall therefore always have a system, either ultra-
ﬁlter or reverse osmosis, capable of removing them. They
should be used for treated water tanks susceptible to
contamination, etc.
They must be very well designed according to the ﬂow
and speed of the circulating water. Other elements in
suspension in the water will greatly reduce the lamp’s
effectiveness.
Maintenance: Lamps have to be replaced once a year to
ensure maximum efﬁciency. Lately, use of this type of
system is falling due to the constant monitoring and
maintenance required, in comparison with dual RO,
which allows more  controlled water puriﬁcation and no
interruption of the dialysis due to failure of one of the RO
units.
Storage  tanks
We  recommend that storage of treated water shall be
avoided as far as possible, especially post osmosis treat-
ment, because of the risk of contamination, the difﬁculty
of disinfecting it and the few barriers from this point to
the patient. Should a storage tank be necessary, it shall
be opaque to prevent growth of algae and have a 0.45 m
hydrophobic vent ﬁlter. Tanks shall also be equipped with
a UV light system and an ultraﬁlter for the retention of
endotoxins at the outlet, and have a conical bottom so
that they drain from their lowest point. Flexible and pres-
surised tanks shall be avoided. It shall be possible to carry
out full disinfection.
Distribution  systems
The distribution system guarantees the supply of water
to dialysis machines and local acid-concentrate produc-
tion systems. We  recommend that it shall be colour
coded to indicate the direction of water ﬂow. The dis-
tribution system must be designed to maintain the
chemical and microbiological quality of water and shall
therefore meet the following criteria:
–  Continuous loop with as short a journey as possible
– Minimum number of connections
– Minimum pressure drop
– Materials compatible with the conditions of use (e.g.
supply, disinfection, cleaning)
– Not release chemical substances or nutrients for
microorganisms (copper, aluminium, lead, zinc, etc.)
– Material with low surface roughness
– Opaque
– At least one sampling point at the end of the distribu-
tion loop
– Avoid dead zones and minimise the distance between
the loop and the connection points to the machines.
Compatible  materials
The choice of materials shall depend on the proposed
disinfection system. The following table is a guide to
material compatibility with disinfection products.
Material compatibility with disinfection products.
Material Sodium
hypochlo-
rite
(Bleach)
Peracetic
acid
Formaldehyde Hot
water
Ozonea
PVC × × × ×
CPVC × × × ×
PVDF × × × × ×
PEX × × × × ×
SS × × × ×
PP × × × ×
PE × × × ×
ABS ×
PTFE × × × × ×
Glass × × × × ×
PVC, polyvinyl chloride; CPVC, chlorinated polyvinyl chloride;
PVDF, polyvinylidene ﬂuoride; PEX, cross-linked polyethylene;
SS, stainless steel; PP, polypropylene; PE, polyethylene; ABS,
acrylonitrile butadiene styrene; PTFE, polytetraﬂuoroethylene.
× indicates compatibility.
a Ozone refers to ozone dissolved in water, not to ozone gas.
The user shall verify the compatibility of the germicide
with the distribution system materials. When consid-
ering compatibility, joints, junctions and the tubing
material shall also be included. Consideration shall also
be given to germicide concentration and the duration,
frequency and conditions of exposure to be applied (ﬂow,
pressure, temperature).If the length of the junction from
the loop to the machine connector is more  than three
times the diameter of the loop, common in hose-type
connections, this section shall be included in routine
disinfection.We recommend that the distribution system
shall be certiﬁed as a medical device.
Distribution  system  disinfection  systems
Disinfection can be carried out by various methods:
(a) Chemical disinfection: performed according to the
schedule deﬁned after plant validation. For chemical
disinfection, we recommend using sodium hypochlo-
rite or peracetic acid. Avoid the use of sodium
hypochlorite for disinfection of osmosis membranes
as it can damage them.
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Most reverse osmosis systems these days enable
easy disinfection of the equipment itself and the
distribution system (if connected online).
Following disinfection, the absence of traces of
disinfectant shall be veriﬁed before performing
dialysis.
(b) Thermal disinfection: Enables disinfection to be
performed automatically. Shall have a system for
temperature monitoring at the most distal point to
ensure that the temperature required by the man-
ufacturer during the disinfection cycles is reached.
Important that the circuits recommended for heat
sterilisation are those manufactured in cross-linked
polyethylene (PEXA), acrylonitrile butadiene styrene
(ABS plastic), PVDF (polyvinylidene ﬂuoride), PTFE
(Teﬂon) or pharmaceutical grade stainless steel.
PVDF
http://www.resinex.es/tipos-de-polimeros/pvdf.
html
http://www.gfps.com/content/gfps/country US/
en US/products/piping/pvdf-sys/sygefstd.html
http://fgf.hu/storage/ﬁle/Product%20Range%
20International%202011%20-%20SYGEF%
20PVDF GFDO 8260 4b.pdf
PTFE
http://www.ﬂuorotherm.com/technical-
information/materials-overview/ptfe-properties/
http://www.merefsa.com/productos/ptfe-
politetraﬂuoretileno/tubos-lisos-y-coarrugados-
de-ptfe pid23.html
http://www.inalcoa.net/catalogo/plasticos-2/
ptfe-marca-teﬂon-%C2%AE/
(c) Ozone disinfection: Enables disinfection to be per-
formed automatically. Where an ozone disinfection
system is used, the concentration of ozone in the air
shall be monitored to ensure that permitted limits
are not exceeded.
A.2.1.4  Other  considerations
The water treatment system shall have pressure gauges,
ﬂow meters, sampling points in the right places for mon-
itoring the water puriﬁcation process, and valves that
enable certain individual elements to be bypassed to
facilitate repair or allow operation of the system in case
of failure.
Electrical circuits shall be separated from the hydraulic
circuits and adequately protected from possible
hydraulic leaks.
Characteristics  of  the  water  treatment  facility
The haemodialysis water treatment facility should be
located as close as possible to the haemodialysis unit
(less than 25 metres). The surface area will be consis-
tent with the number and size of the components. The
design of the water treatment facility has to take into
account the weight of all the equipment (full of water)
and guarantee that the ﬂoor will support it.
We recommend that it shall be at least 25 m2. The ﬂoor
and part of the walls shall be waterproofed. The room
must have a drain to evacuate more  than 5000 l/h. It shall
also have a central sump, which shall be the lowest point
of the room. The room shall be well ventilated with tem-
perature maintained between 15 and 30 ◦C. There shall
be easy access for supplies and, if possible, it shall have
its own access separate from that to the haemodialysis
unit.
If it is has a thermal disinfection system, the drainage
system shall be able to withstand high temperatures
(>90 ◦C).
Location  of  the  water  treatment  facility
It is very important that the facility is close to the
haemodialysis unit and it is not at all advisable to have
one water treatment facility for use by two units some
distance apart. Long runs are not acceptable due to the
risk of contamination.
A.2.2.  Components  of  the  concentrates  for  dialysis
There are two types of concentrate:
– Acid: with ions (Na, K, Ca, Mg, Cl), with slight variations
(mainly in K and Ca) according to the medical pre-
scription, acetic acid to lower the pH and prevent the
precipitation of calcium carbonate that forms when Ca
in the acid concentrate comes into contact with bicar-
bonate when making the dialysis ﬂuid, and sometimes
glucose.
– Bicarbonate: sodium bicarbonate as buffer, sometimes
with sodium chloride.
They can be purchased in containers or small bags to
supply directly to the dialysis machines, in which case
no production system or distribution network is required
and manufacturing shall be the responsibility of the
manufacturer.
They can also be supplied in large tanks, in which case
distribution networks shall be required, but manufactur-
ing shall still be the responsibility of the manufacturer.
If concentrates are to be prepared, there shall be a system
for mixing puriﬁed water and salts, with storage and dis-
tribution for them. It shall also be mandatory to have the
appropriate permit and signature of the person respon-
sible for preparing that product.
A.2.2.1.  Concentrate  preparation
We  do not recommend preparation and storage of dial-
ysis concentrates on-site due to the inherent difﬁculties
and the lack of current regulations in this regard, par-
ticularly in the case of bicarbonate concentrate as it is
easily contaminated. The components of a concentrate
preparation system shall be made of compatible materi-
als to prevent chemical or physical reactions affecting
the concentrate purity. Puriﬁed water shall be avail-
able and appropriate checks shall be made to ensure
e40  n e f r o l o g i a. 2 0 1 6;3  6(3):e1–e52
quality standards and chemical and bacteriological
purity. We  do not recommend preparing, storing or dis-
tributing bicarbonate concentrates in network due to its
instability (it is rapidly degraded to give CO2 and H2O)
and frequent contamination (especially at room temper-
ature). For bicarbonate, we  recommend the use of solid
micronised salt in cartridges; this salt is dissolved in
warm water in the machine during the dialysis session
for immediate use, ensures better dissolution, stability
and purity and is currently the best system for prepara-
tion of the bicarbonate dialysis bath.
A.2.2.2.  Concentrate  distribution
(a) Compatible materials
All components used for the distribution of acid
concentrates for dialysis (storage tanks, pumps and
distribution network) shall be made of materials
compatible with the ﬂuids (plastic materials or stain-
less steel) so that they do not interact and do not
produce chemical contamination.
(b) Design
It may be distributed by gravity from an overhead
tank or via a pressurised circuit by a pump.
In the case of distribution by gravity, the tank shall
be a cone bottom tank with outlet at the bottom
and a spray mechanism to enable cleaning and
disinfection. It shall be closed and have a 0.2 mm
hydrophobic air intake ﬁlter to prevent contamina-
tion, and have a level alarm system.
(c) Acid concentrate distribution
Both the distribution system and the connections to
the dialysis machines shall be colour-coded in red.
There are two distribution layouts: tree system; and
loop system. The tree system delivers the concen-
trate to the points of use along branches. The loop
system delivers the concentrate to the points of use
by way of a loop and continuous ﬂow.
The distribution networks for the different acid con-
centrates and the connection points to the dialysis
machines shall be colour-coded in red with initials
for identiﬁcation.
Although the acid concentrates do not easily become
contaminated with bacteria, the circuits shall be
closed to prevent evaporation or non-bacterial con-
tamination. Regular disinfection is not usually
required but periodic descaling, washes and inspec-
tions are necessary.
(d) Bicarbonate concentrate distribution
Both the distribution system and the connections to
the dialysis machines shall be colour-coded in blue
and shall be different from those in the acid network
to prevent connection errors.
Given that the bicarbonate concentrate is an excel-
lent medium for bacterial growth, the system shall
be designed to enable frequent periodic disinfec-
tion with acid products as descalers, active oxygen
as cleaner and active chlorine or aldehydes as
disinfectants. The system may also be equipped with
an ultraviolet radiation system or an ozone genera-
tor.
A.2.3.  Haemodialysis  machines
Deﬁnition: A haemodialysis machine is a component
designed to mix  the concentrated electrolyte solutions or
powder cartridges with the treated water to an electrolyte
concentration, pH and temperature determined by med-
ical prescription, while at the same time being properly
degassed.1,2 The quantity of electrolytes diluted in the
water is controlled by monitoring the conductivity; the
pH of the ﬁnal solution is sometimes also determined.
The temperature is regulated to be suitable at the point of
contact between the bath and the patient. The absence of
air in the form of microbubbles shall also be guaranteed.
The drainage system for the machines shall be in “free
fall”; this means that there shall be no contact between
the drain from the machine and the plumbing system for
the building in order to prevent contamination from the
sewage system from accessing the machine.
• Compliance of haemodialysis machines with the
standards UNE-EN 60601-1-6, 2010/UNE-EN 60601-
2-16:1999/CORRIGENDUM16 and subsequent if any;
among other aspects, these standards cover monitor-
ing the preparation and temperature of the dialysis
bath. Dialysis machines shall also comply with other
standards for electrical and medical components by
which they may be affected and shall have CE marking.
• Compliance with the manufacturer’s recommenda-
tions for preventive maintenance work1,2 and partic-
ularly monitoring of preparation of the haemodialysis
ﬂuid (degasiﬁcation, heating and electrolyte composi-
tion monitored via the conductivity): proper operation
shall be monitored and veriﬁed according to the man-
ufacturer’s speciﬁcations. All maintenance and repairs
shall be carried out by qualiﬁed staff, either the
manufacturer or distributor of the machine or the
properly trained technical staff of the haemodialysis
unit with the precise technical information, this being
the responsibility of the manufacturer or distributor
of the machine. Measuring devices external to the
machine used for monitoring and veriﬁcation of the
proper preparation of the haemodialysis bath should
be checked periodically, either by specialised labora-
tories, the product manufacturer or using standards
speciﬁcally for that purpose.
• Disinfection and descaling after every dialysis ses-
sion, with absence of any traces of disinfectant agents
in the hydraulic circuit before the start of the new
session.1,12,13,17 Minimum guarantee of proper opera-
tion of the machine by running autotests on the main
parameters. Proper descaling has become an essential
part of guaranteeing, on the one hand, disinfection of
the machine after a dialysis session to avoid possible
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contamination to the next patient and, on the other,
the proper operation of the machine to avoid contin-
uous depositing of material in its various components
(bioﬁlm) that cause errors in the different bath prepa-
ration parameters.
With the use of certain disinfectants or other cir-
cumstances, checks shall be implemented after each
disinfection, to ensure the absence of any traces of
disinfectant agents before commencing a new dialysis
session, using test strips, colorimetry, etc.
The completion of the machine autotests before the
start of each dialysis session has become an important
element in guaranteeing the proper operation of the
machine and thereby signiﬁcantly increasing patient
safety, while providing a guarantee of the machine’s
reliability for the medical, nursing and technical staff.
The autotests generally consist of the simulation of
different conductivity and temperature values to be
compared with default values in the machine itself and
which shall not exceed the default deviation value. The
machines run another series of tests, not discussed
here, where another set of control parameters guar-
anteeing its proper functioning (blood leak detector
[BLD], UF, hydraulic circuit seal, ﬂows, electronic con-
trols and power supplies, etc.) are checked. If any of
the tests are failed, it may be possible to start the dial-
ysis session under the responsibility of the operator.
We do not recommend doing this, and particularly not
repeating session after session. Therefore, if a machine
fails any of the tests, the test shall be repeated and,
if it still does not pass, the machine shall be with-
drawn as soon as possible; in the event of having to
perform haemodialysis with a failed test, the opera-
tor shall closely monitor the operation of the machine,
following the manufacturer’s instructions.
• Inclusion of ultraﬁlter on the dialysate line1,3,11–13. To
complement the use of high-quality water, the use
of ultraﬁlters in machines that ﬁlter the dialysate is
strongly recommended, regardless of the dialysis tech-
nique used (standard/online) or the type of dialyser
(high or low ﬂux).
Their use is mandatory when the “online” dialysis
technique is used or when the dialysers are high-ﬂux,
in order to obtain ultrapure dialysate. The use of this
technique and high-ﬂux dialysers means more  con-
tact between the patient’s blood and the dialysis bath,
so not only is it vital to prevent the possible presence
of pyrogens from the water but also from the dialysis
concentrates, especially containerd bicarbonate.
The inclusion of an ultraﬁlter in the bath line should
include as intrinsic to installation the possibility of
their descaling and disinfection as simply another part
of the circuit, unless they are single-use, in which case
it shall be strictly necessary to comply with the above
requirement. All the equipment necessary for produc-
ing the dialysate must meet certain requirements and
technical speciﬁcations in order to achieve and main-
tain a high quality.18–27
• Recommendation on the useful life of the machines.
Dialysate is produced in the dialysis machine; the age
of the machine, regardless of how well-maintained, is
related to the safety and efﬁciency of that process. We
recommend that haemodialysis machines shall have
a useful life not exceeding 7 years or 30,000 hours of
operation.27,28Recommendation on reserve machines.
Haemodialysis units shall have reserve machines
available for use. The number, between 12% and
20% of the stations in operation, may vary depend-
ing on the age of the machines, availability of
technical services and care in isolation or special
units. There shall be protocols in place for their
maintenance.
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The majority of the bacteria detected in dialysis water are
gram-negative bacilli, generally glucose non-fermenting
bacilli. Using identiﬁcation systems designed for clini-
cally relevant bacteria, the genera most commonly found
are Pseudomonas, Stenotrophomonas, Burkholderia, Achro-
mobacter, Acinetobacter, Ralstonia, Agrobacter, Moraxella etc.
Less common are gram-positive bacilli (identiﬁed as
Corynebacterium) and enterococcus. Fungi are not uncom-
mon  in dialysis water but they are found in lower
quantities than bacteria. The most commonly isolated
fungi are Candida parapsilosis and dematiaceous ﬁlamen-
tous fungi. There are notable differences in the microbial
ﬂora between one hospital and another.1–4
The number of viable bacteria, capable of reproduction,
in the water is determined by cultivating a known quan-
tity of water in a solid culture medium (agar plate) and
counting the number of visible colonies. The number
of colonies is expressed as colony forming units (CFU)
and it depends on the volume of ﬂuid inoculated, the
composition of the culture medium, temperature and
incubation time. For historical reasons, the medium con-
taining sodium chloride, pancreatic enzyme digest of
casein and papaya enzyme digest of soybean meal (com-
monly called TSA) has become the reference medium for
bacterial quantiﬁcation studies in dialysis water. Media
poor in nutrients, such as R2A medium,5 incubated at
room temperature for 14 days, detect more  CFU than
richer media incubated for less time or at a higher
temperature.6 R2A medium is superior to TSA, even if
the other culture conditions are the same.7–10 This cre-
ates a conﬂict: The methods formerly recommended as
reference by the Spanish Royal Pharmacopoeia, the Euro-
pean Pharmacopoeia and the AAMI underestimate the
number of bacteria present in water. Moreover, with
the application of more  sensitive methods, it becomes
more  difﬁcult to maintain the set maximum level of CFU.
Numerous studies have found no correlation between
the number of CFU in water and the amount of endo-
toxin.
To facilitate comparison of our results with those of other
centres, we recommend that commercially available cul-
ture media should be used routinely and that they be
supported by broader experience. To this end, we  recom-
mend the use of Reasoner 2A plates.10
The count of algae and fungi in dialysis water and its
clinical signiﬁcance is a little studied phenomenon. Arbi-
trarily, the maximum allowable fungal count is set at a
number 10 times lower than bacteria.organizacion/sns/planCalidadSNS/docs/EERR/UDE.pdf
[accessed 22.02.16].
Appendix  3.  Microbiological  monitoring
Metabolically, bacteria can be classiﬁed into three large
groups:– Photosynthetic bacteria capable of producing carbohy-
drates using solar energy (cyanobacteria).
–  Chemosynthetic bacteria capable of synthesising their
nutrients and obtaining energy from inorganic com-
pounds.
– Heterotrophic bacteria, which need organic com-
pounds for their development. This is a broad and
diverse group that includes symbiotic, saprophytic and
pathogenic species. The term heterotrophic is com-
monly used as a generic name for water bacteria with
few nutritional requirements.
We  do not recommend any identiﬁcation of microor-
ganisms recovered in culture as it has not been
demonstrated that the clinical signiﬁcance of the counts
varies according to the species present.
Higher bacterial counts are often detected in dialysate
than in the dialysis water (see Guideline 3-1).8 The
bicarbonate concentrate is a medium particularly easily
colonised by bacteria. Units with distribution cir-
cuits for bicarbonate concentrate shall strictly monitor
these circuits. Bacteriological monitoring of dialysis
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concentrates is particularly difﬁcult to standardise since
the microorganisms that reproduce in this environ-
ment have developed coping mechanisms that hinder
their detection in culture. The sensitivity of detection of
these bacteria can also be improved by making media
poor in nutrients to which different concentrations of
bicarbonate9 or sodium chloride11 are added.
The Spanish Royal Pharmacopoeia does not set speciﬁc
limits for fungal contamination in the dialysis water.
What it does do is set out that a speciﬁc culture medium
shall be used for fungi, Sabouraud or similar, and that the
incubation temperature shall be 20–25 ◦C.
A.3.1.  Methods  for  collecting  samples  and  cultures
Taking  samples
Sampling  method.  Microbiological monitoring of puriﬁed
and highly puriﬁed water shall be done weekly during the
month-long validation phase. Subsequently, and during
the maintenance phase, monitoring shall be carried out
at least once a month.
Sampling points:  In the validation period, samples shall be
taken of the following: feed water; softened water; the
treated water immediately pre and post RO; the distri-
bution loop and from at least 10% of the water intakes
for the machines; and the dialysate on entry into the
dialyser. In the maintenance period, it is not necessary
to take samples in the pretreatment, unless signiﬁcant
contamination is detected of the treated water.
The sampling of the water intake ports on the machines
should be done at the start of the dialysis session.
Taking  samples.  The sampling point shall not be cleaned
with disinfectants such as hypochlorite, acetic acid, per-
acetic acid, etc. Use of 70% alcohol is acceptable as long
as it is then left to fully evaporate. We recommend the
use of sterile gloves and that the task of sample collec-
tion is performed between two people, with the aim of
minimising cross-contamination.
If instruments are used to open the safety valve and
allow water to ﬂow out of the dialysis machine connec-
tion ports, these elements shall have been previously
sterilised (autoclave or gas).
The bacterial load of each dialysis water sampling point
shall be taken after letting the stream run over a strictly-
controlled period of time, i.e. 1 minute or, preferably, until
a ﬁxed amount of one litre of water has drained, since the
ﬁrst decilitres of water usually have a signiﬁcantly higher
bacterial load.
The dialysate shall be taken from the machine using a
syringe or a sterile container.12
The samples can be collected in any sterile glass or plastic
container. A 50 ml  urine culture container is suitable for
puriﬁed water. The containers should be labelled before-
hand, stating the collection site. To determine bacterial
load in highly puriﬁed water or dialysate, a sample of over
100 ml  is required.
The containers containing the samples should be kept
on ice or refrigerated at 4 ◦C (between 3 and 6 ◦C) until
processing for culture. The culture should be done in the
shortest time possible, within a maximum of 24 hours.
Culture  procedure.  The number of colonies that can be
reliably counted with the naked eye is between 50 and
200. The methods proposed below are adapted from the
rules of the Spanish Royal Pharmacopoeia, adjusting the
volume inoculated to obtain the highest accuracy in the
range closest to the cut-off. Counts above 200 or below
50 may only be taken into account assuming that they
do not correspond to an approximation of the actual
number, except if there are other plates on which other
amounts or dilutions of the sample have been spread
that enable greater accuracy in the count. It may some-
times be necessary to change the volume of liquid spread
or dilute samples in sterile water to accurately quan-
tify those with a very high level of contamination. The
inoculated volume should never be less than 0.1 ml.
To read the number of colonies, a magnifying glass
(4–10×) should be used, clicking with a hand tally counter
or a punch while counting the colonies. If the mass dilu-
tion method is used, they can be marked with a marker
pen on the underside of the plate.
The culture media most cited are TSA, TGEA and R2A. In
this guideline we  recommend R2A, as it is superior in its
ability to detect microorganisms in water.10 Blood agar is
not recommended, although a comparative study found
that it performed similarly to TSA.
Plate  count  method
The colony count can be done in three ways: by surface-
spread of the sample; by incorporating into a liquid
agar medium (serial dilution or dilution in agar); and
ﬁltration through membrane. The Spanish Royal Phar-
macopoeia, in reference to microbiological monitoring
of products not necessarily sterile, recommends spread-
ing each sample and each sample dilution in duplicate
and using selective media (Sabouraud) for cultivation of
fungi. Given the wide assay ranges for counts in dialy-
sis water and the multiple factors involved, it may not
be essential to quantify the number of viable bacteria so
accurately.
Surface-spread  method
Puriﬁed water:  Use petridishes with R2A. Use  aseptic tech-
nique to inoculate each plate with a volume of 1 ml  of the
sample and spread with an angled sterile loop over the
entire surface of the medium. After the agar has com-
pletely absorbed the inoculated ﬂuid, turn plates upside
down for incubation. The usual plates (9 cm diameter)
may take 1 hour to absorb 1 ml  of water. This time can be
reduced by using plates of 14 cm in diameter.
Incubate the plates at 23–27 ◦C for 7 days, unless a shorter
period allows a more  reliable count to be obtained (large
colonies that can hide other smaller colonies). Record the
number of colony forming units per millilitre.
e44  n e f r o l o g i a. 2 0 1 6;3  6(3):e1–e52
Membrane  ﬁltration
Use membrane ﬁlters with a nominal pore diameter of
0.45 microns or less, and whose effectiveness in retaining
bacteria has been demonstrated. For example, cellulose
nitrate membranes with a nominal pore diameter of 0.22
microns. To force the liquid through the membrane, vac-
uum devices connected to the drain terminal of the ﬁlter
holder can be used. Filtration equipment is designed to
allow easy transfer of the ﬁlter to the culture medium.
If the aim is to detect microorganism concentrations
above 0.1 CFU/ml (highly puriﬁed water), between 100
and 1000 ml  should be ﬁltered. The Spanish Royal Phar-
macopoeia recommends washing each ﬁlter three times
by passing through 100 ml  of a suitable liquid, such as
a solution of peptone-buffered sodium chloride at pH
7.0, every time. If validated, fewer than three washes
may be done. Transfer one of the membrane ﬁlters,
intended primarily for bacteria count, to the surface of
a plate with suitable solid medium such as the R2A
solid medium, and one ﬁlter, intended for fungal count,
to the surface of a plate with suitable solid medium
such as Sabouraud. Incubate the R2A and Sabouraud
plates at room temperature (20–25 ◦C) for 7 days, unless
a shorter period allows a more  reliable count to be
obtained. Select the plates with the greatest number
of colonies but fewer than 100 colonies and calculate
the number of colony forming units per millilitre of
sample.
Sensitivity of
the method
Culture
medium
Volume inoculated Days of
incubation
Temperature
Puriﬁed water Improved R2A 0.2–1 ml  7–14 Room temp.
Highly puriﬁed
water
Improved R2A 100–1000 ml  (ﬁlter) 7–14 Room temp.
Ultrapure
dialysate
Improved R2A 100–1000 ml  (ﬁlter) 7–14 Room temp.
Currently, most of the guidelines, including ISO 2014,
recommend taking readings of cultures at 7 days after
spreading and maintaining the plates at room temper-
ature. This methodology has shown greater sensitivity
than those used previously.12–14
Annex  to  appendix  3.  Composition  of  culture
media
Reasoner R2A medium (modiﬁed according to the
Royal Spanish Pharmacopoeia formula, referred to as
medium S).
Composition
Yeast extract 0.5 g
Proteose-Peptone 0.5 g
Hydrolysed casein 0.5 g
Glucose 0.5 g
Starch 0.5 g
K2HPO4 0.03 g
MgSO4, anhydrous 0.024 g
Sodium pyruvate 0.3 g
Agar 15 g
Water 1000 ml
After sterilisation in autoclave, pH 7.2 ± 0.2 (adjusted with
K2HPO4 or KH2PO4).
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TSA (Bacto Tryptic Soy Agar, Difco = CASO Agar,
medium B).
Composition:
Pancreatic digest of casein 15 g
Papain digest of soybean 5 g
Sodium chloride 5 g
Agar 15 g
Distilled water 1000 ml
The pH shall be adjusted to pH 7.3 ± 0.2.
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A.3.2  Methods  for  collecting  samples  and  endotoxin
testing
Bacterial  endotoxin  assays
From the point of view of this guideline, the bacterial
endotoxin test applies to the determination or quan-
tiﬁcation of endotoxins from gram-negative bacteria. At
present, the method based on the use of circulating
horseshoe crab Limulus polyphemus amoebocyte lysate as
reagent should be used (LAL test).
When the LAL reagent is put in contact with endotoxin-
containing solutions in the presence of divalent cations,
an enzymatic reaction takes place that converts clottable
protein (coagulogen) into a gel (coagulin). The speed of
this reaction depends on the concentration of endotoxin,
the pH and the temperature. With this method, a semi-
quantitative determination of the presence of endotoxin
is obtained. The endpoint determination of the reaction
is done by direct comparison with a control or reference
endotoxin. In all tests for endotoxins, an international
reference endotoxin (E. coli 0113 H10K) is used which
serves as a standard sample for different determinations.
The results are expressed as EU (endotoxin unit) or IU
(International Unit), 1 IU being equivalent to 1 EU (1 IU = 1
EU).
Other spectrophotometric methods (turbidimetric and
chromogenic) have been developed which, via the LAL
test, allow quantitative estimates of endotoxin content.
These methods are based on the appearance of colour
after degradation of a synthetic peptide that contains a
chromophore.
The detection and quantiﬁcation of ET shall be per-
formed with a LAL test, in line with the technical
recommendations of the European Pharmacopoeia and
European Best Practice Guidelines for haemodialysis
(Part 1) NDT 17, suppl.7, 2002. The techniques gener-
ally used are: (1) Gel-Clot method (Mallinckrodt® Inc.),
semi-quantitative method; (2) Turbidimetric technique
(Endosafe®, Charles River Laboratories Inc.), kinetic
method; (3) kinetic chromogenic technique (Endosafe®,
Charles River Laboratories Inc.), the most sensitive. The
ﬁrst two methods are acceptable for testing puriﬁed
water and standard dialysate, but for highly puriﬁed
water and ultrapure dialysate, the third shall be used.
The FDA also published a LAL Test Guideline.1
The samples for ET shall be collected as discussed in
Section 6.2: a 5 ml  sample in a special pyrogen-free plas-
tic tube without adsorptive capacity for ET. Samples shall
be stored frozen and processed as soon as possible.
It is important to remember that there are other bacte-
rial components (both bacterial membrane and bacterial
DNA) which are not detected by standard methods, i.e.
LAL, and can induce activation of immunocompetent
cells. Some of these products are released into the circu-
lation after bacterial lysis, while others, like exotoxins,
are secreted. Many  of these products can diffuse through
the dialysis membrane due to their low molecular weight,
the majority below 10 kD.
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1. Guideline on Validation of the Limulus Amebocyte Lysate
Test as an End-Product Endotoxin Test for Human and
Animal Parenteral Drugs, Biological Products, and Medical
Devices. U.S. Department of Health and Human Services,
It should be remembered that the chlorine and other
disinfectants may alter some types of reverse osmosis
membranes, such as those made of polyamide.
2. Submicron ﬁlters: block bacteria, 0.1 m.
3. Ultraviolet radiation lamps1: capable of destroying all
types of bacteria in their different states. The bacteri-
cidal effect depends on the lamp power, water purity,
ﬂow rate and exposure time. These parameters have
to be well designed to be effective. The lamps have to
be replaced periodically. The danger of this system is
that, if the water is heavily contaminated, the massive
destruction of bacteria can cause a massive release of
endotoxins which may then reach the patient.
4. Ozone disinfection: this gas is unstable, with a half
life in aqueous media of 30 minutes, and is a powerful
oxidising agent. To remove the ozone, a more  powerful
and multi-frequency UV lamp, twice the capacity of
that used as a germicide, is required; for a given ﬂow,
for converting the ozone to molecular oxygen.
Compared to other systems such as chlorination, this
system is more  powerful and has a better cost-beneﬁt
ratio2.
5. Periodic and effective disinfection of the water
treatment plant: we recommend more  frequent dis-
infection in summer, using disinfectant and descaling
agents such as peracetic/acetic acid, hydrogen perox-
ide and to a lesser extent, aldehydes.
Hypochlorites should only be used if the reverse
osmosis membranes are compatible.
6. Hot water disinfection3–6:
Important that the circuits recommended for heat
sterilisation are those manufactured in cross-linked
polyethylene (PEXA), acrylonitrile butadiene styrene
(ABS plastic), PVDF (polyvinylidene ﬂuoride), PTFE
(Teﬂon) or pharmaceutical grade stainless steel.
A material can only properly be disinfected with heat if
it is previously clean.
Hot water can be used to control bacterial growth in
water storage and distribution or dialysis systems. The
exposure time should be according to the manufacturer’s
instructions. The heater shall supply the required hot
water at the right temperature for the necessary time to
all points of the circuit. The effectiveness shall be mon-
itored permanently by bacterial culture and endotoxin
testing.
The ability of hot water to disinfect a distribution system
depends on temperature and exposure time.Public Health Service, Food and Drug Administration. Avail-
able from: http://www.fda.gov/ [accessed 22.02.16].
Appendix  4.  Disinfection  systems
Disinfection systems shall be effective for the inactiva-
tion or removal of microﬂora.
The frequency of disinfection is very important and must
be programmed more  for prevention than for the removal
of contamination.
The disinfection shall reach all elements of the system.
This includes the reverse osmosis membranes (especially
the clean side), the distribution piping, the input lines to
dialysis machines (located between the circuit and the
machines), and the dialysis machine itself (which has its
own circuit and disinfection program).
The disinfection procedure, when applied with appropri-
ate frequency and including the critical areas, shall be
capable of minimising the effects of biological contami-
nation.
UV lamps can be used for inactivation of planktonic
species, but has little or no activity against any bioﬁlm
formed in the system.
It  is important to always refer to the manufacturers’
recommendations and, once disinfected, the absence of
contaminant residue in the circuits shall be conﬁrmed
before reuse.
An adequate disinfection strategy shall be preventive,
and shall be adjusted based on the validation and reval-
idation results.
Germicidal  systems
Disinfection may be carried out using heat or chemicals.
As discussed under pre-treatment, once chlorine and
other oxidising systems are removed, the risk of bacterial
contamination is high. The points at greatest danger of
contamination are ﬁlters, the resins in the water soften-
ers and deionisers and the activated charcoal ﬁlter.
There is also a risk of contamination in the tanks and the
distribution circuit, especially if there are dead zones out
of circulation.
The following are used to combat this:
1. Injection of chlorine at the beginning of pre-
treatment: this is done by the permanent addition
of sodium hypochlorite or hydrochloric acid to the
system, to achieve a concentration of 0.3 mg/l of free
chlorine.
The concept, Ao, is a way of calculating the “dose of ther-
mal  energy necessary” to disinfect, based on different
combinations of time and temperature.
One Ao equals one second at 80 ◦C. (1 Ao = 1 second at
80 ◦C)
Ao = ˙10(T − 80)/z · t
where T is the temperature in ◦C; z equals 10 ◦C; and t
is the time in seconds.
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However, the standard requirements in terms of the tem-
perature and time parameters for a disinfection process
should be based on additional parameters that are rarely
taken into consideration: the frequency or the type of
microorganism.
The frequency shall be programmed to prevent the for-
mation of bioﬁlm. We  recommend that this shall be daily
for the circuit, connection to the machine and ultraﬁlters,
and weekly for the osmosis membranes. The required
quality of water can often be maintained with one or two
thermal disinfections per week.
The effectiveness of thermal disinfection depends on:
Disinfection time
Microbiological activity and type of microorganism
Frequency of disinfection
Temperature of the disinfection water
The dose of thermal disinfection to remove 99.999%
of microorganisms and guarantee the efﬁciency of the
thermal disinfection process anywhere in the facility is
considered to be 12000 Ao.
Automated disinfection systems should be used in the
treated-water distribution circuit; they may operate by
heat or chemicals, or be mixed, and should include an
endotoxin ﬁlter. Automated systems make it easier and
safer to maintain microbiological standards.
We recommend periodically using hypochlorite (bleach)
or some other commercial drain cleaner for the mainte-
nance of the general drainage pipes in order to prevent
or remove any deposits of chemical or organic matter.
Always be aware of the importance of compatibility
between different disinfectants, detergents or descaling
agents, in order to avoid toxicity complications, gases or
even explosions; remembering that this can affect not
only the circuits, but also the drains.
Agent Incompatibility
with. . .
Dangerous with. . .
Acetic acid Bases Hypochlorite
(bleach) Hydrogen
peroxide (H202)
Citric acid Hypochlorite
Hydrogen
peroxide Bases
Hydrogen
peroxide +
Peracetic
acid
Acid concen-
trates Alkali
concentrates
Hypochlorite
Aldehydes Phenol.
Alcohols
Agent Incompatibility
with. . .
Dangerous with. . .
Hypochlorite Acids Hydrogen per-
oxide Aldehydes
Nitrates Phenol.
Alcohols
Aldehydes
(formalde-
hyde and
glutaralde-
hyde)
Acids Ammo-
nia Phenol
Hypochlorite
Hydrogen
peroxide
Hydrochloric acid.
Chlorhexidine
Phenol Alkalis Aldehy-
des
Hypochlorite
Hydrogen
peroxide
Alcohols
(ethanol-
methanol)
Hypochlorite
Hydrogen perox-
ide Potassium
After any chemical disinfection, the substances used
shall be cleared by rinsing and tests shall be performed
to check for residual levels; for example, formaldehyde
<3 mg/l, bleach <0.1 mg/l and ozone <0.1 mg/l.
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Appendix  5.  Monitoring  of  chemical
contaminants
The following table compares the allowable levels of the
elements to be monitored in puriﬁed water from differ-
ent guidelines. We recommend that the main reference
shall be the ISO-13959:2014. The chemical elements have
been divided into three groups according to the criteria
of these standards.
Maximum allowable levels of toxic chemical substances
and dialysate electrolytes in water for dialysis. Values in
mg/l.
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Contaminant ISO-13959:20141
AAMI-13959:2014
European
Pharmacopoeia 4.32
UNE standard
111-301-903
Parametric value in
drinking water, RD
140/20034
Contaminants with documented toxicity in haemodialysis (ﬁrst group)
Aluminiuma 0.01 0.01 0.01 0.2
Total chlorine 0.1 0.1 –  –
Free chlorine – 0.5 0.5 1
Combined chlorine
(chloramines)
– – 0.1 2
Copper 0.1 0.1 0.1 2
Fluoride 0.2 0.2 0.2 1.5
Lead 0.005 0.005 0.005 0.01
Nitrate as N 2 2 2 50
Sulfates 100 50 100 250
Zinc 0.1 0.1 0.1 –
Electrolytes normally included in the dialysate (second group)
Calcium 2 (0.05 mmol/l) 2 2 –
Magnesium 4 (0.15 mmol/l) 2 4 –
Potassium 8 (0.2 mmol/l) 2 8 –
Sodium 70 (3.0  mmol/l) 50 70 200
Maximum levels of other toxic substances (third group)
Antimonyb 0.006 (0.005)a 0.006 – 0.005
Arsenic 0.005 0.005 0.005 0.01
Barium 0.1 0.1 0.1 –
Beryllium 0.0004 0.0004 – –
Cadmium 0.001 0.001 0.001 0.005
Chromium 0.014 0.014 0.014 0.05
Mercury 0.0002 0.0001 0.0002 0.001
Selenium 0.09 0.09 0.09 0.001
Silver 0.005 0.005 0.005 –
Thallium 0.002 0.002 – –
Other substances identiﬁed as toxic in dialysis
Ammonium – 0.2 0.5
Chlorides 50 250
Heavy metals 0.1c 0.1 –
a Recommended <0.005.
b Obviously, the value in water for haemodialysis should not be higher than that allowed in drinking water.
c Recommended when it is not possible to analyse the elements described in the third group and the feed or raw water meets the requirements
of drinking water, according to RD 140/2003.
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We  have taken the standard, UNE 111-301-90, as refer-
ence because, although outdated in several respects, it
is still cited as Spanish regulation. It corresponds to the
AAMI 1981.
The maximum level of these same substances in drinking
water or feed or raw water are indicated as reference; ISO-
13959:2014 indicates the importance of this as feed water;
other national guidelines also specify this testing.5
ISO-13959:2014 provides some exceptions, such as the
elements that it may not be possible to analyse in the
third group,1 which do not need to be taken into consid-
eration in Spain due to the technology in the treatment
of feed water, the regulations on the water to be treated
and the analytical capabilities of the laboratories.
The testing methods are described in ISO-13959:2014 and
European Pharmacopoeia 4.3 01/2003:1167, Page 3049.
Considerations  concerning  some  of  the  elements
Chlorine  and  chloramines
Chlorine is added to potable water as a bactericide
because it is a strong oxidising agent. This function is per-
formed by free chlorine, which quickly dissolves. The way
to maintain stable levels of free chlorine is the forma-
tion of chloramines, mono-, di- and trichloride nitrogen
compounds, which release the chlorine slowly. Chlo-
ramines are able to pass through most water treatment
systems, including reverse osmosis. There are essentially
two systems for removing them from water: reaction
with activated charcoal; and reaction with sodium bisul-
ﬁte. The choice of one system or another depends on
the characteristics of the water to be treated and the
pH these reactions cause. In the case of puriﬁed water
for HD, we recommend activated charcoal as it is eas-
ier to maintain and replace and it removes other organic
products, the proper maintenance and regular renewal
is essential. If small amounts of chloramines cross into
the blood, they cause oxidant effects, the most important
being haemolysis. Chloramines are difﬁcult to measure
so concentrations are usually estimated as the difference
between total chlorine and free chlorine.6 When mea-
sured using this method, the allowable levels should be
at least less than 0.06 mg/l for total chlorine and less than
0.05 mg/l for chloramines.6
Total chlorine is the sum of free chlorine and chlo-
ramines, these in turn being the sum of monochlo-
ramines, dichloramines and nitrogen trichloride.
Aluminium
Another complex issue with dialysate is its aluminium
content. The aluminium in water is present as ions asso-
ciated with salts and in colloidal form, bound to organic
material. Depending on the pH, the ion form can vary
from a trivalent cation to a complex anion. Softeners
only remove the cation forms. Colloidal aluminium is
not removed by electro-deionization systems (DI); the
only process with the capacity to remove it is reverse
osmosis (RO). Aluminium is sometimes added to water as
ﬂocculant for organic matter, so it can be in very high con-
centrations. In such situations, the only way to achieve
optimal levels in the dialysate is to work in series with
two RO or DI-RO.7
We know that the balance of aluminium during dialysis
is established between free or ultraﬁltrable plasma alu-
minium, 5–10% of the total, and the aluminium in the
dialysate and, if we want to create a distinct negative
balance, maintaining Al concentrations in blood below
30–50 g/l, we have to maintain the concentrations in
dialysate below 5 g/l.8 The level of aluminium in the
treated water can be a reference for the proper opera-
tion of the water treatment system; knowing that the
aluminium content in the water to be treated is a maxi-
mum of 200 g/l and that water treatment with two-stage
osmosis is capable of retaining > 98% of ions means that
aluminium levels can be maintained constantly below
5 g/l.
Measuring substances such as aluminium requires a pre-
cise methodology, the use of non-metallic needles and
special tubes, and preventing contamination of any kind.
Iron
Iron is not included among the contaminants, but is
particularly important because of its effect on osmosis
membranes; it can foul membranes, affecting normal
functioning, as it is not removed in the membrane reject.
The maximum level in drinking water is 200 g/l, but
from time to time and due to changes in the facilities,
levels can become higher and then cause the above prob-
lems. Iron levels should therefore be monitored both in
the water to be treated and before entering the osmosis
system.1,9
Monitoring  of  silt  density  index  (SDI)
Measurement of SDI is useful in feed and pre-treated
water and even at some intermediate point of the pre-
treatment. It provides information on the quality of the
water delivered to the reverse osmosis system, the capac-
ity of the pre-treatment to retain particles in suspension,
and the quality of the feed or raw water. Measurement of
SDI is particularly recommended in the event of prema-
ture saturation of the RO system or alterations in any of
the pre-treatment components. Manufacturers of reverse
osmosis membranes and water treatment equipment
indicate a maximum of SDI of 5 pre RO (some manufac-
turers lower this to 3). Changing SDI conditions in the
feed water supply can result in the pre-treatment being
unable to reduce it to the required levels. Monitoring the
SDI becomes an effective tool with a view to implement-
ing measures to protect the RO system equipment and
prevent more  major problems.
r  e  f  e  r  e  n  c  e  s
1. ISO-13959:2014; AAMI-13959:2014.
2.  European Pharmacopoeia 4.301/2003:1167, p. 3049.
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Despite all the regulation, water used for dialysis shall
meet much more  demanding criteria in order to prevent
complications and disease resulting from microbiologi-
cal and chemical contaminants in water from the public
supply. The level of purity required for dialysate has
steadily increased with the introduction of haemodial-
ysis using high-ﬂux membranes and especially the
convective techniques in which the dialysate itself is
infused.
The ﬁrst Spanish regulation for water treatment for
haemodialysis was the UNE 111-301-90 standard. The
1st edition of this guideline published in 2004 set
the standard to follow in terms of water quality for
haemodialysis in Spain and even outside Spain. Many
of Spain’s autonomous regions have used this as a
basis for their technical speciﬁcation documents and
agreements for haemodialysis, although each with its
distinctive features. In 2011, the Ministry of Health, Social
Policy and Equality published a review of standards
and recommendations for renal replacement therapy
(haemodialysis) units, in which all aspects of water treat-
ment for haemodialysis were also based on the 1st
edition of this guideline.
The international standard ISO, which is very close to our
guideline on the cut-off values for microbiological con-
taminants, is gaining increasingly more  followers and it
is being used in some haemodialysis units here in Spain.
The different references for the standards and recom-
mendations are provided below, grouped by product type.
It is important to note that the reference standard is the
ISO 2014 and, in parallel, with identical nomenclature,
the American AAMI recommendations.
Water for public consumption, potable water or feed
water:
A. Regulations:
– ROYAL DECREE 140/2003, of 7 February, establishing
health criteria for the quality of water for human
consumption.
– ROYAL DECREE 865/2003, of 4 July, establishing
health and hygiene criteria for the prevention and
control of Legionnaires’ disease.
Water for haemodialysis and dialysate:
A. Regulations and recommendations:
– Royal Decree 414/1996, of 1 March, regulating med-
ical devices.calidad del agua tratada «on line» y del líquido de diálisis
(L.D.). Nefrología. 2008;28:493–504.
Appendix  6.  Regulations,  recommendations
and  existing  guidelines  on  dialysate  and  its
components
As mentioned in Section 4 of this guideline, as a start-
ing point to be able to produce a quality dialysis ﬂuid,
ﬁrst and foremost is the necessity of having a water
supply that complies with RD 140/2003 on the quality cri-
teria of water for human consumption and RD 865/2003,
which establishes the health and hygiene criteria for
the prevention and control of Legionnaires’ disease. Both
decrees set out the health criteria for the quality of
potable water, construction products used in the distri-
bution and storage system and the actions necessary
for maintenance and conservation of the facilities (see
Appendix 1).
Annex I of RD 140/2003 sets out the maximum allow-
able level for the different chemical and microbiological
parameters in drinking water. Annex II describes the
UNE-EN standards and the Order SSI/304/2013, of 19
February, which derogate Order SAS/1915/2009, of 8 July,
concerning the substances used in the treatment of
drinking water. Regulations for Reference Laboratories,
methods to be used for the determination of the differ-
ent parameters and the testing frequency are all speciﬁed
in the other Annexes. In addition, an information sys-
tem on areas of supply and quality control of drinking
water, the Sistema de Información Nacional de Agua
de Consumo (SINAC) [Spanish Information System for
Drinking Water] (http://sinac.msc.es) has been set up,
through which national annual reports for public infor-
mation are compiled which contain a large amount of
information on the water, including its origin (ground-
water, desalination plants, reservoirs, etc.), treatment
process, disinfection system, microbiological and chem-
ical analyses, etc.
– UNE (Una Norma Espan˜ola) [A Spanish Standard].
AENOR (Asociación Espan˜ola de NORmalización)
[Spanish Association for Standardisation].
• UNE 111301:1990. Characteristics of water used
in haemodialysis.
• UNE EN 13867:2003+A1:2009. Concentrates for
haemodialysis and related therapies.
• UNE for ISO 11663:2014, (BOE-A-2015-5655.pdf)
n e f r o l o g i a. 2 0 1 6;3  6(3):e1–e52 e51
– Renal Replacement Unit, Standards and Recom-
mendations, Reports, Studies and Research 2011.
Ministerio de Sanidad, Política Social e Igual-
dad. http://www.msssi.gob.es/organizacion/sns/
planCalidadSNS/docs/EERR/UDE.pdf
– Real Farmacopea Espan˜ola [Royal Spanish Pharma-
copoeia], 5th Ed. (Feb 2015)
– European Pharmacopoeia. 8th Ed. (2014) https://
www.edqm.eu/en/european-pharmacopoeia-8th-
edition-1563.html
• Concentrated solutions for haemodial-
ysis
2376
• Concentrates for injections or infu-
sions
797
• Conductivity (2.2.38.) 59
• Haemodiaﬁltration and haemoﬁltra-
tion, solutions for
2378
• Haemodialysis, concentrated solutions
for
2376
• Haemodialysis solutions, concen-
trated, water for diluting
2375
• Haemodialysis, solutions for 2376
• Haemoﬁltration and haemodiaﬁltra-
tion, solutions for
2378
• Solutions for haemodialysis 2376
• Solutions for haemodialysis, concen-
trated, water for diluting
2375
• Solutions for haemoﬁltration and
haemodiaﬁltration
2378
• Solutions for peritoneal dialysis 2994
• Water for diluting concentrated
haemodialysis solutions
2375
• Water for injections 3555
• Water, highly puriﬁed 3559
• Water, puriﬁed 3561
– AAMI (Association for the Advancement of Medical
Instrumentation). http://www.aami.org
Using the same nomenclature as ISO standards
since 2011. Required for “Centers for Medicare
and Medicaid Services (CMS)”
• ANSI/AAMI/ISO 11663:2014 Quality of dialysis
ﬂuid for hemodialysis and related therapies.
• ANSI/AAMI/ISO 13958:2014 Concentrates for
hemodialysis and related therapies.
• ANSI/AAMI/ISO 13959:2014 Water for hemodial-
ysis and related therapies.
• ANSI/AAMI/ISO 23500:2014 Guidance for the
preparation and quality management of ﬂuids
for hemodialysis and related therapies.
– ISO. (International Organization Standardization).
http://www.iso.org
International standards with which compliance is
voluntary.
• ISO 11663 2014 Quality of dialysis ﬂuid for
haemodialysis and related therapies
• ISO 13958 2014 Concentrates for haemodialysis
and related therapies
• ISO 13959 2014 Water for haemodialysis and
related therapies
• ISO 23500 2014 Guidance for the preparation and
quality management of ﬂuids for haemodialysis
and related therapies
B. Guidelines:
– Guideline for Dialysate Quality (GDQ). 2004.
http://www.senefro.org/modules/webstructure/
ﬁles/gua calidad agua mar06.pdf?check idﬁle=1368
– UK Renal Association and Association of Renal
Technologist. Guideline on water treatment facil-
ities, dialysis water and dialysis ﬂuid quality of
haemodialysis and related therapies. 2012
– European Best Practice Guidelines for Haemodial-
ysis (part 1) Nephrol. Dial. Transplant. 2002:17
(Suppl. 7): 45–62
– The following do not cover water for HD or
dialysate:
• Kidney Disease Outcomes Quality Initiative
(KDOQI) guidelines
• Kidney Disease Improving Global Outcomes
(KDIGO) guidelines
• Canadian Society of Nephrology (CSN) guidelines
• Caring for Australasian with Renal Impairment
(CARI) guidelines
Medical electrical equipment (MD)
This is a non-implantable medical device (NIMD) and
as such, subject to European and national regulations
(i.e. RD 1591/2009, Medical Devices Directive, 93/42/CEE,
ISO13485, IEC 60601.1:2015), whose general requirements
in terms of design and manufacturing must be met
to be in compliance and which are monitored by the
Agencia Espan˜ola del Medicamento y Productos Sanitar-
ios (AEMPS) [Spanish Agency of Medicines and Medical
Devices] among other authorities.
- http://www.aemps.gob.es/productosSanitarios/
prodSanitarios/home.htm
- http://www.aenor.es/aenor/normas/normas/
ﬁchanorma.asp?tipo=N&codigo=N0051276&pdf=
- http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?
uri=CONSLEG:1993L0042:20071011:EN:PDF
- https://www.boe.es/diario boe/txt.php?id=BOE-A-
2009-17606
- http://www.iso.org/iso/home/store/catalogue ics/
catalogue detail ics.htm?csnumber=65529
By deﬁnition, MEDICAL DEVICE is any instrument, appa-
ratus, appliance, software programme or other article,
whether used alone or in combination, intended by the
manufacturer to be used in human beings for the pur-
pose of diagnosis, prevention, monitoring, treatment or
alleviation of disease.
Dir. 2007/47 http://www.boe.es/doue/2007/247/L00021-
00055.pdf
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Haemodialysis equipment:
– UNE (Una Norma Espan˜ola) [A Spanish Standard].
AENOR (Asociación Espan˜ola de NORmalización)
[Spanish Association for Standardisation].
• UNE-EN 60601-2-16 CORR:2000. Medical electrical
equipment - Part 2-16: Particular requirements for
the safety of haemodialysis, haemodiaﬁltration and
haemoﬁltration equipment.
• UNE-EN 60601-2-16:1999. Equipos electromédicos.
Part 2-16: Particular requirements for the safety of
haemodialysis, haemodiaﬁltration and haemoﬁltra-
tion equipment.
• Renal Replacement Unit, Standards and Recom-
mendations, Reports, Studies and Research 2011.
Ministerio de Sanidad, Política Social e Igualdad”
http://www.msssi.gob.es/organizacion/sns/plan
CalidadSNS/docs/EERR/UDE.pdf
ISO. (International Organization Standardization).
• ISO 26722 2014 Water treatment equipment for
haemodialysis applications and related therapies
AAMI (Association for the Advancement of Medical
Instrumentation)
• ANSI/AAMI/ISO 26722:2014 Water treatment equip-
ment for hemodialysis applications and related
therapies.
